World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol 2018; 24(30): 3361-3373 [PMID: 30122876 DOI: 10.3748/wjg.v24.i30.3361]
URL:	https://www.wjgnet.com/1007-9327/full/v24/i30/3361.htm

(328) (380) (0) (0) (0) (19) (3) (38223) (450)

Number	Citing Articles
1	Emre Hoca, Bilal Cangir, Süleyman Ahbab, Seher İrem Şahin, Ece Çiftçi Öztürk, Ayşe Öznur Urvasızoğlu, Nilsu Kalaycı, İsmail Engin, Hayriye Esra Ataoğlu. The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients. Diagnostics 2025; 15(16) doi: 10.3390/diagnostics15162045
2	Chowdhury F Zaman, Jakia Sultana, Proma Dey, Jui Dutta, Sadia Mustarin, Nuzhat Tamanna, Aditi Roy, Nisha Bhowmick, Mousumi Khanam, Sadia Sultana, Selia Chowdhury, Farjana Khanam, Md Sakibuzzaman, Priyata Dutta. A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.29657
3	Xiangyu Guo, Xunzhe Yin, Zuojia Liu, Jin Wang. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences 2022; 23(24) doi: 10.3390/ijms232415489
4	Hua Liu, Yang-Min Hao, Sheng Jiang, Maiheliya Baihetiyaer, Cheng Li, Guo-Yao Sang, Zhiming Li, Guo-Li Du. Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment. International Journal of General Medicine 2024; doi: 10.2147/IJGM.S460200
5	Satya Sundar Gajendra Mohapatra , Nija Mani . Global Best Practices in Healthcare Management: A Comparative Analysis. Health Leadership and Quality of Life 2022; 1 doi: 10.56294/hl2022172
6	Yejin Kim, Yoosoo Chang, Min-Jung Kwon, Yun Soo Hong, Mi Kyung Kim, Won Sohn, Yong Kyun Cho, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults. American Journal of Gastroenterology 2021; 116(11) doi: 10.14309/ajg.0000000000001344
7	Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!. Metabolism 2019; 101 doi: 10.1016/j.metabol.2019.154001
8	Erenie Guirguis, Yasmin Grace, Anthony Bolson, Matthew J. DellaVecchia, Melissa Ruble. Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(3) doi: 10.1002/phar.2489
9	Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, Benedicto Crespo Facorro. Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis. Data in Brief 2019; 27 doi: 10.1016/j.dib.2019.104415
10	Chanh-Phong Tran, John J Kim, Jordan J Feld, William WL Wong. Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluation. Canadian Liver Journal 2021; 4(4) doi: 10.3138/canlivj-2021-0011
11	Jinyao Liu, Yumiko Oba, Seiko Yamano. Chronic ethanol consumption plus an atherogenic diet cause metabolic steatohepatitis with advanced liver fibrosis in apolipoprotein E/low‐density lipoprotein receptor double‐knockout mice. Alcoholism: Clinical and Experimental Research 2022; 46(7) doi: 10.1111/acer.14852
12	Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies. F1000Research 2023; 11 doi: 10.12688/f1000research.109134.3
13	Rehab E Ashmawy, Oleg Blyuss, Dimitrinka Nikolova, Chavdar S Pavlov, Christian Gluud, Paola J Andrenacci. Bile acids for metabolic dysfunction-associated steatotic liver disease in adults. Cochrane Database of Systematic Reviews 2025; 2025(9) doi: 10.1002/14651858.CD014850
14	Francesco Tovoli, Silvia Ferri, Fabio Piscaglia. Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease. Current Pharmaceutical Design 2020; 26(32) doi: 10.2174/1381612826666200429093648
15	Kozue Kanemitsu-Okada, Masanori Abe, Yoshiko Nakamura, Teruki Miyake, Takao Watanabe, Osamu Yoshida, Yohei Koizumi, Masashi Hirooka, Yoshio Tokumoto, Bunzo Matsuura, Mitsuhito Koizumi, Yoichi Hiasa. Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2023; 24(3) doi: 10.3390/ijms24032509
16	Sheng Yang, Chong Liu, Xiaowen Ji, Xuemin Chen, Yun Wang, Rong Tao. The Role of Gold Nanorods in Detecting Circulating microRNAs as Biomarkers in Liver Diseases. Journal of Biomedical Nanotechnology 2023; 19(10) doi: 10.1166/jbn.2023.3676
17	Guanghui Deng, Chang Liu, Jiamin Zhao, Ming Wang, Yunjia Li, Menghan Yang, Haixin Ye, Junjie Li, Mengchen Qin, Chaofeng Wu, Hao Shi, Yuxin Liao, Zhaoxi Zhou, Shiqing Zhang, Ken Kin Lam Yung, Lei Gao. Exocarpium Citri Grandis alleviates the aggravation of NAFLD by mitigating lipid accumulation and iron metabolism disorders. Journal of Ethnopharmacology 2023; 313 doi: 10.1016/j.jep.2023.116559
18	Morteza Aghajanpoor, Mehrzad Gholampourdehaki, Reza Mosaed, Iraj Mirzaii-Dizgah, Afsaneh Vosughi. The Efficacy of Empagliflozin in Combination with Pioglitazone on the Improvement of Fatty Liver Disease in Patients with Type 2 Diabetes. Annals of Military and Health Sciences Research 2024; 22(2) doi: 10.5812/amh-144009
19	Yang Xia, Limin Cao, Qing Zhang, Li Liu, Shunming Zhang, Ge Meng, Hongmei Wu, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Adherence to a vegetable dietary pattern attenuates the risk of non‐alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort study. Journal of Internal Medicine 2022; 291(4) doi: 10.1111/joim.13428
20	Xiaoyan Li, Hua Wang. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00507-y
21	Inês H. Vieira, Luísa M. Barros, Carla F. Baptista, Dírcea M. Rodrigues, Isabel M. Paiva. Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes. Clinical Diabetes 2022; 40(1) doi: 10.2337/cd21-0043
22	Anastasios Semertzidis, Thomai Mouskeftara, Helen Gika, Petros Pousinis, Kali Makedou, Antonis Goulas, Jannis Kountouras, Stergios A. Polyzos. Effects of Combined Low-Dose Spironolactone Plus Vitamin E versus Vitamin E Monotherapy on Lipidomic Profile in Non-Alcoholic Fatty Liver Disease: A Post Hoc Analysis of a Randomized Controlled Trial. Journal of Clinical Medicine 2024; 13(13) doi: 10.3390/jcm13133798
23	Banshi Saboo, Sanjay Agarwal, Brij Mohan Makkar, Rajeev Chawla, Sujoy Ghosh, Vijay Viswanathan, Sunil Gupta, Ch. Vasanth Kumar, Anuj Maheshwari, L. Sreenivasamurthy, Rakesh Kumar Sahay, Sanjay Reddy, Shalini Jaggi, Jugal Kishor Sharma, Vijay Panikar, Anand Moses, Bikash Bhattacharjee, Pratap Jethwani, Sudhir Bhandari, J. P. S. Sawhney, Shashank Joshi, Saumitra Ray, S. V. Madhu, Bipin Sethi. RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus. International Journal of Diabetes in Developing Countries 2022; 42(1) doi: 10.1007/s13410-022-01063-6
24	Jonathan Mertens, Christophe De Block, Maarten Spinhoven, Ann Driessen, Sven M. Francque, Wilhelmus J. Kwanten. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.768576
25	S. V. Bulgakova, Yu. A. Dolgikh, L. A. Sharonova, O. V. Kosareva, E. V. Treneva, P. Ya. Merzlova, D. P. Kurmayev. Modern aspects of therapy of metabolic associated liver disease in patients with type 2 diabetes mellitus. Meditsinskiy sovet = Medical Council 2024; (16) doi: 10.21518/ms2024-414
26	Muhammad Radzi Abu Hassan, Rosaida Hj Md Said, Zalwani Zainuddin, Haniza Omar, Siti Maisarah Md Ali, Siti Aishah Aris, Huan-Keat Chan. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Heliyon 2023; 9(6) doi: 10.1016/j.heliyon.2023.e16652
27	Yang Xia, Shunming Zhang, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Xue Bao, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Insoluble dietary fibre intake is associated with lower prevalence of newly-diagnosed non-alcoholic fatty liver disease in Chinese men: a large population-based cross-sectional study. Nutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-019-0420-1
28	Rodrigo Valenzuela, Luis A. Videla. Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View. Nutrients 2020; 12(2) doi: 10.3390/nu12020499
29	Anne M. Misher, Jennifer L. Rosselli, Christine A. Schumacher, Michael See. The Role of the Diabetes Care and Education Specialist in Caring for Diabetes Complications and Common Comorbid Conditions. ADCES in Practice 2021; 9(3) doi: 10.1177/2633559X211002805
30	Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, Laura Canesi, Ilaria Demori. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. Planta Medica 2022; 88(01) doi: 10.1055/a-1273-3159
31	Kenny Mendoza, Víctor Eduardo Villalobos-Daniel, Alejandra Jáuregui, Isabel Valero-Morales, César Hernández-Alcaraz, Nelson Zacarías-Alejandro, Ricardo Omar Alarcon-Guevara, Simón Barquera. Development of a crowdsourcing- and gamification-based mobile application to collect epidemiological information and promote healthy lifestyles in Mexico. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56761-4
32	Martin M. Grajower. Nonalcoholic Steatohepatitis. JAMA 2020; 324(9) doi: 10.1001/jama.2020.10434
33	Guoqiong Xu, Yuanyuan Wu, Jie Chen, Dan Xiang, Dongji Li. The relationship between muscle mass and fat content in body composition and non-alcoholic fatty liver disease in the Chinese general population: a cross-sectional study. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1384366
34	Mengyang Xia, Yixuan Lu, Feiyang Yin, Zhiqiang Cao, Ping Yao, Hongxia Li. The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention. Journal of Gastroenterology 2025; 60(5) doi: 10.1007/s00535-025-02220-4
35	Somaya Albhaisi. Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?. EMJ Hepatology 2019; doi: 10.33590/emjhepatol/10311541
36	Shimaa Abdelsattar, Hiba S. Al-Amodi, Hala F. M. Kamel, Zeinab A. Kasemy, Ehab Darwish, Asmaa Mosbeh, Ayman A. Sakr, Hanaa M. Elgazzar, Mervat Abdelkareem, Mai Abozeid, Shimaa K. Zewain, Hanan M. Bedair, Sabry M. Abdelmageed. Impact of genotyping (PTPN2, rs2542151) and (MBOAT7, rs641738) in prediction of fibrosis in Metabolic dysfunction- associated steatotic liver disease’ patients. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1615162
37	Luis Vega, Daniela Simian, Abraham I. Gajardo, Marcelo Salinas, Andrea Urra, Máximo Cattaneo, Rosario Pino, Juan P. Roblero, Álvaro Urzúa, Katherine Rojas, Jaime Poniachik. Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis. Annals of Hepatology 2024; 29(4) doi: 10.1016/j.aohep.2024.101511
38	Leilei Yu, Ruohan Zhao, Chen Wang, Chengcheng Zhang, Chuanqi Chu, Jianxin Zhao, Hao Zhang, Qixiao Zhai, Wei Chen, Heng Zhang, Fengwei Tian. Effects of garlic supplementation on non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Journal of Functional Foods 2022; 99 doi: 10.1016/j.jff.2022.105294
39	Rachelle Haber, Fatima Zarzour, Malak Ghezzawi, Natalie Saadeh, Dania S. Bacha, Lama Al Jebbawi, Marlene Chakhtoura, Christos S. Mantzoros. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism 2024; 26(5) doi: 10.1111/dom.15501
40	Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study. Ultrasound in Medicine & Biology 2022; 48(9) doi: 10.1016/j.ultrasmedbio.2022.05.005
41	Yang Xia, Qijun Wu, Huixu Dai, Jiale Lv, Yashu Liu, Hui Sun, Yuting Jiang, Qing Chang, Kaijun Niu, Yuhong Zhao. Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.642509
42	Ruihong Dai, Miaomiao Sun, Mei Lu, Lanhua Deng. Deep learning for predicting fibrotic progression risk in diabetic individuals with metabolic dysfunction-associated steatotic liver disease initially free of hepatic fibrosis. Heliyon 2024; 10(13) doi: 10.1016/j.heliyon.2024.e34150
43	Mohamed Kamal Shaker, Mohamed Hassany, Basem Eysa, AbdulMoneim Adel, Ahmed Zidan, Shahnaz Mohamed. The activity of a herbal medicinal product of Phyllanthus niruri and Silybum marianum powdered extracts (Heptex®) in patients with apparent risk factors for nonalcoholic steatohepatitis: a phase II, multicentered, randomized, double-blind, placebo-controlled clinical trial. BMC Complementary Medicine and Therapies 2025; 25(1) doi: 10.1186/s12906-024-04692-y
44	Sahar H. Elhini, Engy A. Wahsh, Ahmed A. Elberry, Nadia F. El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A. Elsayed, Hoda M. Rabea. The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals 2022; 15(12) doi: 10.3390/ph15121516
45	Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2023; 42(6) doi: 10.1016/j.clnu.2023.03.021
46	Joana Rigor, Andreia Diegues, José Presa, Pedro Barata, Daniela Martins-Mendes. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population. Postgraduate Medicine 2022; 134(4) doi: 10.1080/00325481.2022.2058285
47	Mahboobe Hosseinikia, Farhad Oubari, Roghaye Hosseinkia, Zibaneh Tabeshfar, Mohammad Gharib Salehi, Zeinab Mousavian, Mehrnaz Abbasi, Mehnoosh Samadi, Yahya Pasdar. Quercetin supplementation in non-alcoholic fatty liver disease. Nutrition & Food Science 2020; 50(6) doi: 10.1108/NFS-10-2019-0321
48	Abeer Abdel-latif, Ula Mabid Al-Jarhi, Dina Hesham, Mona khozam, Shaimaa A. Fathy. Sex hormone binding globulin (SHBG) as a predictor of liver fibrosis in subjects with nonalcoholic fatty liver disease (NAFLD). The Egyptian Journal of Internal Medicine 2023; 35(1) doi: 10.1186/s43162-023-00220-5
49	Rebuma Sorsa, Niguse Hamba, Daba Abdissa, Zelalem Banjaw, Hawi Gobena, Muntaha Hamza, Melese Abere, Tilahun Alemayehu Nigatu, Eric Gumpricht. Experimental Evaluation of Dose‐Dependent Hepatorenal Toxicity of Traditionally Prepared Arak in Swiss Albino Mice. Journal of Nutrition and Metabolism 2025; 2025(1) doi: 10.1155/jnme/9304159
50	Nan Xia, Yuqi Cheng, Jin Liu, Li Dong, Jiahuan Li, Hanbo Li, Fanfan Meng, Yi Zhu, Jianjie Qin. Efficacy of digital-based exercise intervention in adults with metabolic associated fatty liver disease: study protocol for a randomised controlled trial in Nanjing, China. BMJ Open 2025; 15(8) doi: 10.1136/bmjopen-2024-095151
51	Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
52	Omer Vehbi Alpaydin, Eda Nur Duran, Ayse Hur Alpaydin, Iskender Ekinci, Seyma Dumur, Hafize Uzun, Murat Akarsu, Isa Yalcinkaya, Omur Tabak. The Importance of Serum Perilipin-2 Level as an Early Indicator of Inflammation in Non-Alcoholic Fatty Liver Disease. Diagnostics 2025; 16(1) doi: 10.3390/diagnostics16010106
53	Feryal Savari, Seyed Ali Mard. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment. Heliyon 2024; 10(7) doi: 10.1016/j.heliyon.2024.e28468
54	Kamlesh K. Bhopale, Mukund P. Srinivasan. Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). Livers 2023; 3(4) doi: 10.3390/livers3040040
55	Wanying Geng, Wanying Liao, Xinyuan Cao, Yingyun Yang. Therapeutic Targets and Approaches to Manage Inflammation of NAFLD. Biomedicines 2025; 13(2) doi: 10.3390/biomedicines13020393
56	Jennifer Linge, Patrik Nasr, Arun J. Sanyal, Olof Dahlqvist Leinhard, Mattias Ekstedt. Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD. JHEP Reports 2023; 5(3) doi: 10.1016/j.jhepr.2022.100663
57	Lu Zhong, Xiaojuan Peng, Chutian Wu, Qing Li, Yanfang Chen, Min Wang, Yuting Li, Kaiyin He, Ying Shi, Caiqun Bie, Shaohui Tang. Polysaccharides and flavonoids from cyclocarya paliurus modulate gut microbiota and attenuate hepatic steatosis, hyperglycemia, and hyperlipidemia in nonalcoholic fatty liver disease rats with type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries 2023; 43(2) doi: 10.1007/s13410-022-01080-5
58	Maximilian J. Ganz, Sascha T. Bender, Christian Gross, Katrin Bose, Peter R. Mertens, Florian G. Scurt. Metabolisches Syndrom und Nierenkrankheiten. Die Nephrologie 2022; 17(5) doi: 10.1007/s11560-022-00595-6
59	Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A. Hill, Dimitri P. Mikhailidis, Christos S. Mantzoros. Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological Reviews 2024; 76(3) doi: 10.1124/pharmrev.123.001087
60	Hong-Xiang Jiang, Ya-Ge Li, Chao Sun, Lan Zhou, Jing Wang, Wen-Fei Wang, Jun Liang. Revealing action mechanisms of Xiaoyaosan decoction for the treatment of nonalcoholic fatty liver in mice employing tandem mass tag quantitative proteomics. Journal of Pharmacy and Pharmacology 2026; 78(2) doi: 10.1093/jpp/rgaf109
61	Yiwei Ma, Xinyue Ding, Jie Gu, Shengmin Zhou, Yuanrong Jiang. Effects of olive oil on hepatic steatosis and liver enzymes: A systematic review. Journal of Functional Foods 2023; 109 doi: 10.1016/j.jff.2023.105815
62	Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of view. Exploration of Medicine 2020; 1(3) doi: 10.37349/emed.2020.00007
63	Yuichiro Eguchi, Gabriel Wong, Omar Akhtar, Yoshio Sumida. Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review. Hepatology Research 2020; 50(6) doi: 10.1111/hepr.13502
64	Eric R. Yoo, Donghee Kim, Luis M. Vazquez‐Montesino, Jessica A. Escober, Andrew A. Li, Sean P. Tighe, Christopher T. Fernandes, George Cholankeril, Aijaz Ahmed. Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality. Liver International 2020; 40(4) doi: 10.1111/liv.14374
65	Alessia De Masi, Xiaoxu Li, Dohyun Lee, Jongsu Jeon, Qi Wang, Seoyeong Baek, Onyu Park, Adrienne Mottis, Keno Strotjohann, Alexis Rapin, Hoe-Yune Jung, Johan Auwerx. Cyclo(His-Pro): A further step in the management of steatohepatitis. JHEP Reports 2023; 5(9) doi: 10.1016/j.jhepr.2023.100815
66	Kanza Saeed, Muhammad Farhan Jahangir Chughtai, Samreen Ahsan, Tariq Mehmood, Muhammad Zubair Khalid, Adnan Khaliq, Muhammad Zuhair, Waseem Khalid, Tawfiq Alsulami, Douglas Law, Emery Lenge Mukonzo. Hepatoprotective Effect of a Kalanchoe pinnata –Based Beverage Against Carbon Tetrachloride– and Gentamicin-Induced Hepatotoxicity in Wistar Rats . Journal of the American Nutrition Association 2025; 44(5) doi: 10.1080/27697061.2024.2442615
67	Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. World Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113 Abstract(1147) \| Core Tip(1074) \| Full Article(HTML)(6960) \| Full Article (PDF)-4296K(765) \| Full Article (Word)-348K(109) \| Audio-7287K(28) \| Peer-Review Report-200K(229) \| Answering Reviewers-203K(256) \| Times Cited (13) \| Total Visits (8370) \| Open
68	Tongxi Zhuang, Wei Li, Li Yang, Zhengtao Wang, Lili Ding, Mingmei Zhou. Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.731288
69	Fangfei Xie, Hong Zhou, Yun Wang. Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1112-6
70	David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still. “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”. Obesity Science & Practice 2021; 7(5) doi: 10.1002/osp4.509
71	Minal Patel. Evidence-based management of patients with nonalcoholic fatty liver disease. JAAPA 2022; 35(8) doi: 10.1097/01.JAA.0000840492.53680.59
72	Guanghui Deng, Junjie Li, Manping Huang, Yunjia Li, Hao Shi, Chaofeng Wu, Jiamin Zhao, Mengchen Qin, Chang Liu, Menghan Yang, Yunqing Wang, Yuxue Zhang, Yuxin Liao, Chuying Zhou, Jian Yang, Yunsheng Xu, Bin Liu, Lei Gao. Erchen decoction alleviates the progression of NAFLD by inhibiting lipid accumulation and iron overload through Caveolin-1 signaling. Journal of Ethnopharmacology 2024; 319 doi: 10.1016/j.jep.2023.117320
73	Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa. The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review. Endocrine and Metabolic Science 2021; 3 doi: 10.1016/j.endmts.2021.100089
74	Stavroula Zagkou, Valentine Marais, Narimane Zeghoudi, Edouard Le Guillou, Eeva-Liisa Eskelinen, Ganna Panasyuk, Bernard Verrier, Charlotte Primard. Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation. Pharmaceutics 2022; 14(7) doi: 10.3390/pharmaceutics14071379
75	Xin Tang, Yongkang Zhou, Fei Liu, Botao Wang, Bingyong Mao, Qiuxiang Zhang, Jianxin Zhao, Wei Chen, Shumao Cui. A Pueraria lobata root extract alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating the gut microbiota and associated metabolites. Food Bioscience 2024; 59 doi: 10.1016/j.fbio.2024.103746
76	Yuxiu Liu, Shiying Liu, Jiaofeng Huang, Yueyong Zhu, Su Lin. Validation of five hepatic steatosis algorithms in metabolic‐associated fatty liver disease: A population based study. Journal of Gastroenterology and Hepatology 2022; 37(5) doi: 10.1111/jgh.15799
77	Danial Fotros, Azita Hekmatdoost, Zahra Yari. Obesity as a predictor of atherogenic dyslipidemia in patients with metabolic dysfunction associated steatotic liver disease. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-35525-2
78	Ting-Yu Chen, Ya-Ling Chen, Wan-Chun Chiu, Chiu-Li Yeh, Yu-Tang Tung, Hitoshi Shirakawa, Wei-Tzu Liao, Suh-Ching Yang. Effects of the Water Extract of Fermented Rice Bran on Liver Damage and Intestinal Injury in Aged Rats with High-Fat Diet Feeding. Plants 2022; 11(5) doi: 10.3390/plants11050607
79	Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies. F1000Research 2023; 11 doi: 10.12688/f1000research.109134.2
80	Rebecca Sewter, Susan Heaney, Amanda Patterson. Coffee Consumption and the Progression of NAFLD: A Systematic Review. Nutrients 2021; 13(7) doi: 10.3390/nu13072381
81	Xiaojun Yu, Lin Xie, Yufen Zhou, Xiaoqin Yuan, Yunlin Wu, Ping Chen. Patients with non‑alcoholic fatty liver disease may be a high‑risk group for the development of colorectal polyps: A cross‑sectional study. World Academy of Sciences Journal 2020; 2(6) doi: 10.3892/wasj.2020.71
82	Suranjan Panigrahi, Ridhi Deo, Edward A. Liechty. A New Machine Learning-Based Complementary Approach for Screening of NAFLD (Hepatic Steatosis). 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021; doi: 10.1109/EMBC46164.2021.9629507
83	Hannah Drescher, Sabine Weiskirchen, Ralf Weiskirchen. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Cells 2019; 8(8) doi: 10.3390/cells8080845
84	Cui Ma, Fuxi Wang, Kang Huang, Qingyu Zhao, Junmin Zhang, Wei Si. 18β-Glycyrrhetinic acid ameliorates hepatic fibrosis through modulating bile acid profile and inhibiting TGF-β/SMAD3 pathway. Food Research International 2026; 242 doi: 10.1016/j.foodres.2026.119818
85	Patrick T. Campbell, Lisa B. VanWagner, Laura A. Colangelo, Cora E. Lewis, Anne Henkel, Veeral H. Ajmera, Donald M. Lloyd‐Jones, Douglas E. Vaughan, Sadiya S. Khan. Association between plasminogen activator inhibitor‐1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA. Liver International 2020; 40(5) doi: 10.1111/liv.14417
86	Zoran Gluvic, Ratko Tomasevic, Ksenija Bojovic, Milan Obradovic, Esma R. Isenovic. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice Guidelines. Emergency and Critical Care Medicine 2022; 2(1) doi: 10.1097/EC9.0000000000000016
87	Renata Risi, Rossella Tozzi, Mikiko Watanabe. Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction. Current Opinion in Clinical Nutrition & Metabolic Care 2021; 24(4) doi: 10.1097/MCO.0000000000000762
88	Non-Neoplastic Diseases of the Liver. 2022; doi: 10.55418/9781933477183-9
89	Ahmad Delbari, Shadi Naderyan Feli, Ali Reza Amirabadizadeh, Mahtab Niroomand, Mohammad Bidkhori, Fernando Guerrero-Romero. Prevalence and associated factors of dyslipidemia in elderly people: Results from the Ardakan Cohort Study on Ageing, Iran. PLOS ONE 2024; 19(10) doi: 10.1371/journal.pone.0306388
90	Joshua Tseng, Jeremy Korman, Mazen Noureddin, Daniel Shouhed, James P. Miller, Xiaoxi Feng, Miguel Burch. Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH. Obesity Surgery 2022; 32(2) doi: 10.1007/s11695-021-05797-w
91	Dieter Furthner, Daniel Weghuber, Christopher Dalus, Andreas Lukas, Hannah N. Stundner-Ladenhauf, Harald Mangge, Thomas Pixner. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps. Hormone Research in Paediatrics 2022; 95(2) doi: 10.1159/000518595
92	Ferya Celik, Merve Yuksel, Hicran Bektas. Effect of E-Health-Assisted Lifestyle Interventions on Weight Loss in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD, Formerly NAFLD): A Meta-Analysis. Western Journal of Nursing Research 2026; 48(3) doi: 10.1177/01939459251400493
93	Muhammad Masroor, Zeba Haque. HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2019.00046
94	Shaikh H. Fawwad, Manthanbhai S. Patel, Sonia Dziugieł, Razan Alfaki, Muhammad Tamoor Akhtar Shaikh, Kapil Khanal, Pratik Lamichhane, Shantaram Barali. Effects of sodium-glucose co-transporter-2 inhibitors on body composition and liver fat markers in non-alcoholic fatty liver disease: a narrative review. Annals of Medicine & Surgery 2025; 87(10) doi: 10.1097/MS9.0000000000003826
95	Abdulrahman Ismaiel, Stefan-Lucian Popa, Dan L. Dumitrascu, Quirino Lai. Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur”. Canadian Journal of Gastroenterology and Hepatology 2020; 2020 doi: 10.1155/2020/8825615
96	Yazhi Wang, Hui Chen. Clinical application of cluster analysis in patients with newly diagnosed type 2 diabetes. Hormones 2025; 24(1) doi: 10.1007/s42000-024-00593-4
97	Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica 2022; 158(11) doi: 10.1016/j.medcli.2021.12.003
98	Rehab F. Abdel-Rahman. Non-alcoholic fatty liver disease. Asian Pacific Journal of Tropical Biomedicine 2022; 12(3) doi: 10.4103/2221-1691.338919
99	Renate L. Hall, Elena S. George, Audrey C. Tierney, Anjana J. Reddy. Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Advances in Nutrition 2023; 14(3) doi: 10.1016/j.advnut.2023.01.001
100	Preethi Chandrasekaran, Ralf Weiskirchen. The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis. International Journal of Molecular Sciences 2024; 25(2) doi: 10.3390/ijms25021109
101	Ricard Corcelles, Juan S. Barajas-Gamboa, Joana Ferrer-Fàbrega, Matthew Kroh. Cirugía bariátrica en trasplante hepático: tendencias actuales y perspectivas futuras. Cirugía Española 2022; 100(2) doi: 10.1016/j.ciresp.2021.04.025
102	Reda M. Mansour, Sherif S. Abdel Mageed, Ahmed I. Abulsoud, Ghadir A Sayed, Radwa H. Lutfy, Farah A. Awad, Mohamed M. Sadek, Abanoub A. S. Shaker, Osama A. Mohammed, Mustafa Ahmed Abdel-Reheim, Hanan Elimam, Ahmed S. Doghish. From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH. Functional & Integrative Genomics 2025; 25(1) doi: 10.1007/s10142-025-01544-x
103	Kelly Casler, Amanda Chaney. Cirrhosis. Nursing 2021; 51(2) doi: 10.1097/01.NURSE.0000731828.24893.bb
104	Sze Zee Lim, Kee Huat Chuah, Ruveena Bhavani Rajaram, Khoo Stanley, Shahreedhan Shahrani, Wah Kheong Chan, Shiaw Hooi Ho, Ida Normiha Hilmi, Khean Lee Goh, Sanjiv Mahadeva. Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single‐center observational study. Journal of Gastroenterology and Hepatology 2022; 37(9) doi: 10.1111/jgh.15905
105	Stephen D. H. Malnick, Pavel Alin, Marina Somin, Manuela G. Neuman. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. International Journal of Molecular Sciences 2022; 23(24) doi: 10.3390/ijms232416226
106	Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
107	Tiantian Song, Shuchun Chen, Hang Zhao, Fei Wang, Huan Song, Dongliang Tian, Qiwen Yang, Licui Qi. Meta‐analysis of the effect of sodium–glucose cotransporter 2 inhibitors on hepatic fibrosis in patients with type 2 diabetes mellitus complicated with non‐alcoholic fatty liver disease. Hepatology Research 2021; 51(6) doi: 10.1111/hepr.13645
108	Norbert Stefan, Marek Hartleb, Branko Popovic, Rafael Varona. Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial. Trials 2024; 25(1) doi: 10.1186/s13063-024-08208-4
109	M. V. Kruchinina, M. V. Parulikova, A. V. Belkovets, K. Yu. Nikolaev, A. K. Ovsyannikova. Features of the fatty acid profile of erythrocyte membranes in patients with fatty liver disease of alcoholic genesis. Meditsinskiy sovet = Medical Council 2023; (18) doi: 10.21518/ms2023-391
110	Dou-Dou Li, Jia-Min Ma, Ming-Jing Li, Lu-Lu Gao, Yan-Na Fan, Yan-Nan Zhang, Xiu-Juan Tao, Jian-Jun Yang. Supplementation of Lycium barbarum Polysaccharide Combined with Aerobic Exercise Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis via AMPK/PPARα/PGC-1α Pathway. Nutrients 2022; 14(15) doi: 10.3390/nu14153247
111	Azadeh Hojreh, Julia Lischka, Dietmar Tamandl, Dariga Ramazanova, Amra Mulabdic, Susanne Greber-Platzer, Ahmed Ba-Ssalamah. Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric Obesity. Nutrients 2023; 15(3) doi: 10.3390/nu15030558
112	Benedikt Kaufmann, Nick Seyfried, Daniel Hartmann, Phillipp Hartmann. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 325(1) doi: 10.1152/ajpgi.00017.2023
113	Danqing Hu, Peng Wang, Xiaojing Wang, Xue Hu, Da Huang, Weiming Yan, Dong Xi, Meifang Han, Qin Ning, Hongwu Wang. Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD. Journal of the Formosan Medical Association 2024; 123(7) doi: 10.1016/j.jfma.2023.12.001
114	Daniel Faurholt-Jepsen, Henrik Friis, David L. Mwaniki, Michael K. Boit, Lydia U. Kaduka, Inge Tetens, Dirk L. Christensen, Giacomo Pucci. Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults. PLOS ONE 2021; 16(2) doi: 10.1371/journal.pone.0247600
115	Saber Ghiassi, Maher El Chaar, Essa M. Aleassa, Fady Moustarah, Sofiane El Djouzi, T. Javier Birriel, Ann M. Rogers. ASMBS position statement on the relationship between obesity and cancer, and the role of bariatric surgery: risk, timing of treatment, effects on disease biology, and qualification for surgery. Surgery for Obesity and Related Diseases 2020; 16(6) doi: 10.1016/j.soard.2020.03.019
116	Asaad Gammal, Taher Nassar, Yael Soae, Noam Freeman, Amit Badihi, Saja Baraghithy, Alina Nemirovski, Joseph Tam, Simon Benita. Synthesis and Pharmacological Characterization of Novel Peripheral Cannabinoid-1 Receptor Blockers Based on a Tricyclic Scaffold. Journal of Medicinal Chemistry 2025; 68(9) doi: 10.1021/acs.jmedchem.4c03132
117	Eduardo Lemos De Souza Bastos, Almino Ramos Cardoso. The Perfect Sleeve Gastrectomy. 2020; doi: 10.1007/978-3-030-28936-2_3
118	Jiasen Wei, Chenglong Ji, Lina Liu, Chen Yan, Linhui Han, Wenbo Lin, Ximing Xu, Kaiqiang Sun. Cross-disease biomarker identification reveals shared diagnostic biomarkers for IVDD and NAFLD via bulk and single-cell RNA sequencing. Frontiers in Molecular Neuroscience 2025; 18 doi: 10.3389/fnmol.2025.1639705
119	Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shuixian Du, Quanjiang Dong, Yongning Xin, Shiying Xuan. Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review). Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7781
120	Abdulrahman Ismaiel, Blal El Hosiny, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Cristina Sorina Catana, Dan L. Dumitrascu. Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7) doi: 10.1016/j.clinre.2023.102160
121	Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, Karin Hepp Schwambach, Cristiane Valle Tovo, Carine Raquel Blatt. Drug-induced liver injury and COVID-19: A review for clinical practice. World Journal of Hepatology 2021; 13(9): 1143-1153 doi: 10.4254/wjh.v13.i9.1143 Abstract(1130) \| Core Tip(1050) \| Full Article(HTML)(4932) \| Full Article (PDF)-636K(648) \| Full Article (Word)-126K(193) \| Audio-727K(159) \| Peer-Review Report-197K(263) \| Answering Reviewers-111K(273) \| Times Cited (27) \| Total Visits (6408) \| Open
122	Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Angiology 2022; 73(8) doi: 10.1177/00033197221091317
123	Muhammad Masroor, Zeba Haque, Haya Anwar, Farina Hanif, Waqas Ahmed Farooqui. Association of APOC3 and PNPLA3 genetic polymorphism in adult Pakistani population with non-alcoholic fatty liver disease. Human Gene 2025; 45 doi: 10.1016/j.humgen.2025.201453
124	Yongin Cho, Yong-ho Lee. State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis. Endocrinology and Metabolism 2022; 37(1) doi: 10.3803/EnM.2022.102
125	Elizabeth R. M. Zunica, Elizabeth C. Heintz, Christopher L. Axelrod, John P. Kirwan. Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers 2022; 14(16) doi: 10.3390/cancers14164051
126	Chayanis Kositamongkol, Thammanard Charernboon, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Chonticha Auesomwang, Tullaya Sitasuwan, Phunchai Charatcharoenwitthaya, Pochamana Phisalprapa. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome. Medicine 2021; 100(44) doi: 10.1097/MD.0000000000027640
127	Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar. A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals. Journal of Gastroenterology and Hepatology 2021; 36(6) doi: 10.1111/jgh.15353
128	Shirley Yuk-Wah Liu, Vincent Wai-Sun Wong, Simon Kin-Hung Wong, Grace Lai-Hung Wong, Carol Man-sze Lai, Candice Chuen-Hing Lam, Sally She-Ting Shu, Henry Lik-Yuen Chan, Enders Kwok-Wai Ng. A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83782-0
129	Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena Shirokova, Kirill M Starostin. Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. BMJ Open Gastroenterology 2019; 6(1) doi: 10.1136/bmjgast-2019-000307
130	Zhilu Xu, Wenyi Zhu, Qiyun Xia, Wenli Huang, Yuanyuan Chi, Haoyu Qi, Oi Yee Pessy Chan, Jessica YL Ching, Francis KL Chan, Nor Norman Chan, Siew C. Ng. Synbiotics and antioxidants synergistically attenuate disease progression in metabolic dysfunction-associated steatotic liver disease. Biomedicine & Pharmacotherapy 2026; 201 doi: 10.1016/j.biopha.2026.119656
131	Mbang Kooffreh-Ada, Dorathy Chioma Okpokam, Kitu David Emeng, Gift Thomas Eteng, Nkeiruka Ogo Ogidi, Chukwuka Onyedikachim Opara, Ehijie Xavier Iyamah, Ogha Eyamnzie Okpokam. Thrombin Time Clotting Assay as a Predictor Marker of Bleeding Risk in Individuals with Non-Alcoholic Fatty Liver Disease in Calabar, Nigeria. Trends in Biological Sciences 2025; 1(4) doi: 10.21124/tbs.2025.306.315
132	Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
133	Yestle Kim, Joseph Medicis, Matthew Davis, Dominic Nunag, Robert Gish. Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study. Journal of Comparative Effectiveness Research 2024; 13(12) doi: 10.57264/cer-2024-0096
134	Xiongfeng Pan, Shi Wu Wen, Atipatsa C. Kaminga, Aizhong Liu. Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65051-8
135	Priyanka Bhandari, Amit Sapra, Mohitkumar S Ajmeri, Christine E Albers, Devanshika Sapra. Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?. Cureus 2022; doi: 10.7759/cureus.23806
136	Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, Joseph M Pappachan. Management of metabolic-associated fatty liver disease: The diabetology perspective. World Journal of Gastroenterology 2023; 29(1): 126-143 doi: 10.3748/wjg.v29.i1.126 Abstract(1187) \| Core Tip(1100) \| Full Article(HTML)(7102) \| Full Article (PDF)-1366K(645) \| Full Article (Word)-809K(78) \| Audio-1087K(25) \| Peer-Review Report-888K(203) \| Answering Reviewers-138K(192) \| Times Cited (50) \| Total Visits (9312) \| Open
137	Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina. Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. SAGE Open Medicine 2020; 8 doi: 10.1177/2050312120933804
138	Anna Laitakari, Joona Tapio, Kari A. Mäkelä, Karl-Heinz Herzig, Franziska Dengler, Helena Gylling, Gail Walkinshaw, Johanna Myllyharju, Elitsa Y. Dimova, Raisa Serpi, Peppi Koivunen. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. Journal of Molecular Medicine 2020; 98(5) doi: 10.1007/s00109-020-01903-0
139	Philip Berry, Sreelakshmi Kotha. The Challenging Ethical Landscape of Non-alcoholic Fatty Liver Disease. EMJ Hepatology 2022; doi: 10.33590/emjhepatol/21-00217
140	Nuria Perez-Diaz-del-Campo, Jose I. Riezu-Boj, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Fermín I. Milagro, Josep A. Tur, Itziar Abete, M. Angeles Zulet, J. Alfredo Martinez. Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study. Diagnostics 2021; 11(6) doi: 10.3390/diagnostics11061083
141	Shengnan Tang, Jin Wu, Shanshan Xu, Qi Li, Jian He. Clinical-radiomic analysis for non-invasive prediction of liver steatosis on non-contrast CT: A pilot study. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1071085
142	Ana J. F. C. Aguiar, Jaluza L. C. de Queiroz, Pedro P. A. Santos, Christina S. Camillo, Alexandre C. Serquiz, Izael S. Costa, Gerciane S. Oliveira, Ana F. T. Gomes, Lídia L. R. Matias, Rafael O. A. Costa, Thaís S. Passos, Ana H. A. Morais. Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study. International Journal of Molecular Sciences 2021; 22(18) doi: 10.3390/ijms22189968
143	Caroline Chong Nguyen, Denis Duboc, Dominique Rainteau, Harry Sokol, Lydie Humbert, Philippe Seksik, Adèle Bellino, Hendy Abdoul, Naïm Bouazza, Jean-Marc Treluyer, Malika Saadi, Karim Wahbi, Heithem Soliman, Benoit Coffin, André Bado, Maude Le Gall, Olivier Varenne, Henri Duboc. Circulating bile acids concentration is predictive of coronary artery disease in human. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02144-y
144	Jennifer Linge, Mattias Ekstedt, Olof Dahlqvist Leinhard. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Reports 2021; 3(1) doi: 10.1016/j.jhepr.2020.100197
145	Yousuf Zafar, Muhammad Umer Sohail, Muhammad Saad, Syed Zaeem Ahmed, Muhammad Ovais Sohail, Javaid Zafar, Seth Lirette, Ashwani Singal. eHealth interventions and patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. BMJ Open Gastroenterology 2025; 12(1) doi: 10.1136/bmjgast-2024-001670
146	Fátima Higuera-de-la-Tijera, Jacqueline Córdova-Gallardo, Elizabeth Buganza-Torio, Beatriz Barranco-Fragoso, Aldo Torre, Sara Parraguirre-Martínez, Martin Edgardo Rojano-Rodríguez, Gabriel Quintero-Bustos, Graciela Castro-Narro, Carlos Moctezuma-Velazquez. Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value. Digestive Diseases and Sciences 2021; 66(12) doi: 10.1007/s10620-020-06821-2
147	Silvia Ferri, Bernardo Stefanini, Lorenzo Mulazzani, Margherita Alvisi, Francesco Tovoli, Simona Leoni, Luca Muratori, Tommaso Lotti, Alessandro Granito, Luigi Bolondi, Fabio Piscaglia. Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients 2022; 14(12) doi: 10.3390/nu14122493
148	Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International 2020; 14(6) doi: 10.1007/s12072-020-10094-2
149	Iresha Sandamali Koralegedara, Janith Niwanthaka Warnasekara, Ashani Rathnayake, Korale Gedara Dayaratne, Suneth Buddhika Agampodi. Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy. BMJ Open Gastroenterology 2022; 9(1) doi: 10.1136/bmjgast-2022-000913
150	Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1) doi: 10.1210/endrev/bnz009
151	A.J. Scheen. Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications. Diabetes & Metabolism 2019; 45(3) doi: 10.1016/j.diabet.2019.01.008
152	Luisa Barana, Georgia Colleluori, Maria Teresa Sulpizi, Kathleen Ortenzi, Luca Farano, Carmine Giuseppe Fanelli, Riccardo Calafiore, Laura Dalla Ragione, Simone Pampanelli. Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating. Journal of Diabetes & Metabolic Disorders 2022; 21(2) doi: 10.1007/s40200-022-01085-1
153	Yunpeng Gu, Wei Zhang, Yanli Hu, Yutong Chen, Junping Shi. Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studies. Journal of Affective Disorders 2022; 301 doi: 10.1016/j.jad.2021.12.128
154	Kenneth W. Chow, Pragyat Futela, Aryan Saharan, Sammy Saab. Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(5) doi: 10.1016/j.jceh.2023.01.016
155	Tae Jung Oh, Kyuho Kim, Jae Hoon Moon, Sung Hee Choi, Nam H Cho, Hak Chul Jang. Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort Study. Journal of the Endocrine Society 2021; 5(10) doi: 10.1210/jendso/bvab123
156	Stephen A. Harrison, Vlad Ratziu, Jeremy Magnanensi, Yacine Hajji, Sylvie Deledicque, Zouher Majd, Christian Rosenquist, Dean W. Hum, Bart Staels, Quentin M. Anstee, Arun J. Sanyal. NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study. Journal of Hepatology 2023; 79(3) doi: 10.1016/j.jhep.2023.04.031
157	Giulia Besutti, Lisa Bonilauri, Elisa Manicardi, Francesco Venturelli, Efrem Bonelli, Filippo Monelli, Valeria Manicardi, Luca Valenti, Guido Ligabue, Susanna Schianchi, Marco Massari, Nicoletta Riva, Elisabetta Froio, Elena Tagliavini, Pierpaolo Pattacini, Paolo Giorgi Rossi. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study. Diabetes Research and Clinical Practice 2021; 177 doi: 10.1016/j.diabres.2021.108882
158	М. В. Кручинина, М. В. Паруликова, Н. Е. Першина, Э. В. Кручинина. Жирные кислоты мембран эритроцитов как биомаркеры неалкогольной жировой болезни печени у мужчин. Ateroscleroz 2023; 18(4) doi: 10.52727/2078-256X-2022-18-4-362-380
159	Stergios A. Polyzos, Eun Seok Kang, Chrysoula Boutari, Eun-Jung Rhee, Christos S. Mantzoros. Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. Metabolism 2020; 111 doi: 10.1016/j.metabol.2020.154203
160	Shuo Wang, Min Zhao, Zihan Su, Dan Yang, Runqing Mu. Annual biological variation and personalized reference intervals of 8 serum liver enzymes and 3 noninvasive tests in fatty liver patients. Clinica Chimica Acta 2025; 569 doi: 10.1016/j.cca.2025.120156
161	Jiajun Qiu, Maobin Kuang, Shiming He, Changhui Yu, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1302322
162	Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism 2019; 92 doi: 10.1016/j.metabol.2018.11.014
163	Taisiia Turankova, Oleg Blyuss, Alexey Brazhnikov, Andrey Svistunov, Kurinchi Selvan Gurusamy, Chavdar S Pavlov. Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD013670
164	Xueqi Li, Xianjue Huang, Guangwen Cheng, Jing Liang, Luping Qiu, Jubo Zhang, Qiyuan Yao, Hong Ding. Optimizing the number of valid measurements for the attenuation coefficient to assess hepatic steatosis in MAFLD patients: A study of 139 patients who underwent liver biopsy. Ultraschall in der Medizin - European Journal of Ultrasound 2024; 45(04) doi: 10.1055/a-2178-5022
165	Gianni BELCARO, David M. COX, M. Rosaria CESARONE, Giuseppe GIZZI, Luciano PELLEGRINI, Claudia SCIPIONE, Valeria SCIPIONE, Mark DUGALL, Shu HU, Marcello CORSI, Beatrice FERAGALLI, Roberto COTELLESE. Effects of Robuvit® on the progression of non-alcoholic fatty liver disease. Minerva Gastroenterology 2022; 68(4) doi: 10.23736/S2724-5985.22.03201-6
166	Liyuan Hao, Shenghao Li, Guo Chen, Xiaoyu Hu. Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural product. Chemical Biology & Drug Design 2024; 103(2) doi: 10.1111/cbdd.14461
167	Simona Cernea, Itamar Raz. NAFLDin type 2 diabetes mellitus: Still many challenging questions. Diabetes/Metabolism Research and Reviews 2021; 37(2) doi: 10.1002/dmrr.3386
168	Manal H. El-Sayed, Rasha A. Thabet, Mohamed T. Hamza, Muhammad S. Hussein, Maha M. El Saeed. Liver disease in children and adolescents with type 1 diabetes mellitus: A link between glycemic control and hepatopathy. Diabetes Research and Clinical Practice 2020; 170 doi: 10.1016/j.diabres.2020.108458
169	Ahmad Mahdi Ahmad, Heba Mohammed Ali. Comparative effects of two exercise training programs on health-related quality of life in middle-aged women with non-alcoholic fatty liver disease. Advances in Rehabilitation 2020; 34(4) doi: 10.5114/areh.2020.100186
170	Juan Li, Mingxing Yin, Maoxian Tian, Jianguo Fang, Hanlin Xu. Stiff-Soft Hybrid Biomimetic Nano-Emulsion for Targeted Liver Delivery and Treatment of Early Nonalcoholic Fatty Liver Disease. Pharmaceutics 2024; 16(10) doi: 10.3390/pharmaceutics16101303
171	Yan Sun, Nie Zhang, Yun-Long Ding, Li-Jiang Yu, Jun Cai, De Ma, Wu Yang, Wang-Kun Lu, Jia-Li Niu. Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control study. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1063-y
172	Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo, Francisco Javier Bosques-Padilla. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World Journal of Hepatology 2021; 13(11): 1494-1511 doi: 10.4254/wjh.v13.i11.1494 Abstract(962) \| Core Tip(982) \| Full Article(HTML)(5925) \| Full Article (PDF)-1505K(650) \| Full Article (Word)-567K(217) \| Audio-880K(29) \| Peer-Review Report-214K(219) \| Answering Reviewers-47K(199) \| Times Cited (7) \| Total Visits (7367) \| Open
173	Amedeo Lonardo. Metabolomic signature: one step forward in the process of obtaining NAFLD patients’ metabolic identity card. The American Journal of Clinical Nutrition 2022; 115(3) doi: 10.1093/ajcn/nqab399
174	Livhuwani P. Nendouvhada, Nicole R. S. Sibuyi, Adewale O. Fadaka, Samantha Meyer, Abram M. Madiehe, Mervin Meyer, Kwazikwakhe B. Gabuza. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115571
175	Sara De Nucci, Caterina Bonfiglio, Rosanna Donvito, Martina Di Chito, Nicole Cerabino, Roberta Rinaldi, Annamaria Sila, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Elsa Lanzilotta, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity. Nutrients 2023; 15(20) doi: 10.3390/nu15204468
176	Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
177	Peizuo Zhao, Weidong Yang, Huiyu Xiao, Shuaishuai Zhang, Chuanzhou Gao, Hua Piao, Lihong Liu, Shuzhuang Li. Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53644-6
178	Julia N. Ryabenko, Elina B. Ryabenko. Hoficin and remaxol effects on metabolic intoxication and lipid peroxidation in patients with chronic non-calculous cholecystitis on the background of diffuse liver diseases. RUDN Journal of Medicine 2025; 29(2) doi: 10.22363/2313-0245-2025-29-2-265-274
179	Muhammad Usman, Nabiyah Bakhtawar. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials . Cureus 2020; doi: 10.7759/cureus.9018
180	Julia Teck. Diabetes-Associated Comorbidities. Primary Care: Clinics in Office Practice 2022; 49(2) doi: 10.1016/j.pop.2021.11.004
181	Yahya Pasdar, Farhad Oubari, Mahin Nikougoftar Zarif, Mehrnaz Abbasi, Azizollah Pourmahmoudi, Mahboobe Hosseinikia. Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot Study. Clinical Nutrition Research 2020; 9(1) doi: 10.7762/cnr.2020.9.1.11
182	Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271 doi: 10.1016/j.lfs.2021.119220
183	Rita Basu, Mazen Noureddin, Jeanne M. Clark. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers. Mayo Clinic Proceedings 2022; 97(9) doi: 10.1016/j.mayocp.2022.04.005
184	Rohitash Jamwal, Benjamin J. Barlock. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes. Pharmaceuticals 2020; 13(9) doi: 10.3390/ph13090222
185	Carlos Benítez, Juan Pablo Arab, Francisco Barrera, Jesus M. Banales, Marco Arrese. NAFLD and NASH. 2020; doi: 10.1007/978-3-030-37173-9_13
186	D. Yu. Venidiktova, A. V. Borsukov. Non-drug treatment of non-alcoholic fatty liver disease: evaluation of effectiveness with ultrasound steatometry. Medical alphabet 2020; (10) doi: 10.33667/2078-5631-2020-10-38-42
187	Mingshan Guo, Qianyu Pan, Xiaojin Shi, W. Du, S. Grasso. The Comparison and Contrast on NAFLD between the East and the West: Metabolic Mechanism, Dietary Habits, and Policies. E3S Web of Conferences 2021; 308 doi: 10.1051/e3sconf/202130802021
188	Eira Cerda-Reyes, Alicia Sarahi Ojeda-Yuren, Julián Torres-Vazquez, María del Rosario Herrero Maceda, Martín Uriel Vázquez-Medina, Perla Denice Flores-Rangel, Yailin Fabiola Velásquez Palacios, Saraid Cerda-Reyes, Graciela Elia Castro-Narro. Advances in Hepatology. 2021; doi: 10.5772/intechopen.96281
189	Danielle Chi, Meghan Burk. What You Should Know About Fatty Liver Disease. ADCES in Practice 2020; 8(4) doi: 10.1177/2633559X20928918
190	Valentin Blank, David Petroff, Sebastian Beer, Albrecht Böhlig, Maria Heni, Thomas Berg, Yvonne Bausback, Arne Dietrich, Anke Tönjes, Marcus Hollenbach, Matthias Blüher, Volker Keim, Johannes Wiegand, Thomas Karlas. Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75227-x
191	Amirreza Naseri, Sarvin Sanaie, Sina Hamzehzadeh, Sepideh Seyedi-Sahebari, Mohammad-Salar Hosseini, Elnaz Gholipour-khalili, Ehsan Rezazadeh-Gavgani, Reza Majidazar, Parya Seraji, Sara Daneshvar, Erfan Rezazadeh-Gavgani. Metformin: new applications for an old drug. Journal of Basic and Clinical Physiology and Pharmacology 2023; 34(2) doi: 10.1515/jbcpp-2022-0252
192	Adela Gabriela Ştefan, Diana Clenciu, Adina Mitrea, Ionela Mihaela Vladu, Diana Cristina Protasiewicz-Timofticiuc, Maria Magdalena Roşu, Daniela Teodora Maria, Ilie Robert Dinu, Theodora Claudia Gheonea, Beatrice Elena Vladu, Ion Cristian Efrem, Eugen Moţa, Maria Moţa. Metabolic Syndrome and Insulin Resistance in Romania. International Journal of Molecular Sciences 2025; 26(6) doi: 10.3390/ijms26062389
193	Rasika Pradeep Herath, Shirom R. Siriwardana, Chanil D. Ekanayake, Vikum Abeysekara, Sajith U. A. Kodithuwakku, Himali P. Herath, Jonathan M. Peterson. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study. PLOS ONE 2019; 14(4) doi: 10.1371/journal.pone.0215326
194	Ghulam Fatima, Kaneez Zainab Rabail, Mona Humaira, Afsana Khaskheli, Benazir Bughio, Kashaf Nida. Frequency of Liver Fibrosis by Non Invasive Marker in Patients with Non-Alcohol Fatty Liver Diseases. Pakistan Journal of Health Sciences 2023; doi: 10.54393/pjhs.v4i02.572
195	Jia Han, Xin Guo, Tomoyuki Koyama, Daichi Kawai, Jing Zhang, Reimon Yamaguchi, Xiaolei Zhou, Yoshiharu Motoo, Takumi Satoh, Sohsuke Yamada. Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse Model. Nutrients 2021; 13(10) doi: 10.3390/nu13103455
196	Chuanrui Ma, Xinyu Wang, Jing Zhang, Yun Zhao, Yunqing Hua, Chao Zhang, Guobin Zheng, Guangyan Yang, Jianli Guan, Huahuan Li, Meng Li, Lin Kang, Jiaqing Xiang, Guanwei Fan, Shu Yang. Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.893336
197	Vera Francisco, Maria Jesus Sanz, José T. Real, Patrice Marques, Maurizio Capuozzo, Djedjiga Ait Eldjoudi, Oreste Gualillo. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?. Biology 2022; 11(8) doi: 10.3390/biology11081237
198	Zahra Heidari, Zahra Sharafi. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iranian South Medical Journal 2022; 25(1) doi: 10.52547/ismj.25.1.30
199	Vittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer. Nutrients 2023; 15(11) doi: 10.3390/nu15112521
200	Jun Noichi, Tomoko Ishiakawa, Ikuyo Ichi, Yoko Fujiwara. Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse model. Journal of Clinical Biochemistry and Nutrition 2022; 70(2) doi: 10.3164/jcbn.21-69
201	Farzad Salmanizadeh, Sakineh Sabzevari, Sara Shafieipour, Mohammad Javad Zahedi, Afshin Sarafinejad. Challenges and needs in the management of non-alcoholic fatty liver disease from the perspective of gastroenterology and hepatology specialists: a qualitative study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03921-z
202	Xueqi Li, Wenjun Ma, Ting Yang, Chong Wang, Wei Zhang, Hui Li, Ting Zhao, Xiaofei Guo. Higher intakes of lysine, threonine and valine are inversely associated with non-alcoholic fatty liver disease risk: a community-based case-control study in the Chinese elderly. Food Science and Human Wellness 2024; 13(1) doi: 10.26599/FSHW.2022.9250016
203	Haiyan Liu, Jie Xu, Hui Li, Lina Zhang, Pingzhen Xu. Network pharmacology‐based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease. The Anatomical Record 2021; 304(11) doi: 10.1002/ar.24770
204	Valeria Calcaterra, Vittoria Magenes, Matteo Vandoni, Clarissa Berardo, Luca Marin, Alice Bianchi, Erika Cordaro, Giustino Silvestro, Dario Silvestri, Vittoria Carnevale Pellino, Cristina Cereda, Gianvincenzo Zuccotti. Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity. Children 2022; 9(8) doi: 10.3390/children9081174
205	Feng-Zhi Xin, Ze-Hua Zhao, Rui-Nan Zhang, Qin Pan, Zi-Zhen Gong, Chao Sun, Jian-Gao Fan. Folic acid attenuates high-fat diet-induced steatohepatitis <i>via</i> deacetylase SIRT1-dependent restoration of PPARα. World Journal of Gastroenterology 2020; 26(18): 2203-2220 doi: 10.3748/wjg.v26.i18.2203 Abstract(1573) \| Core Tip(1243) \| Full Article(HTML)(7845) \| Full Article (PDF)-16222K(755) \| Full Article (Word)-1729K(346) \| Audio-803K(21) \| Peer-Review Report-249K(322) \| Answering Reviewers-243K(306) \| Times Cited (41) \| Total Visits (10629) \| Open
206	L. B. Lazebnik, E. V. Golovanova, S. V. Turkina, K. L. Raikhelson, S. V. Okovityy, O. M. Drapkina, I. V. Maev, A. I. Martynov, G. E. Roitberg, O. V. Khlynova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, A. O. Bueverov, E. V. Vinitskaya, G. V. Volynets, E. Yu. Eremina, V. B. Grinevich, A. I. Dolgushina, A. N. Kazyulin, E. I. Kashkina, I. V. Kozlova, Yu. V. Konev, N. V. Korochanskaya, Yu. A. Kravchuk, E. D. Li, I. D. Loranskaya, V. M. Makhov, S. N. Mekhtiev, V. P. Novikova, O. D. Ostroumova, Ch. S. Pavlov, V. G. Radchenko, A. A. Samsonov, A. S. Sarsenbaeva, R. G. Sayfutdinov, P. V. Seliverstov, S. I. Sitkin, O. V. Stefanyuk, L. V. Tarasova, E. I. Tkachenko, Yu. P. Uspensky, Yu. A. Fominykh, A. I. Khavkin, Yu. V. Tsyganova, O. O. Sharhun. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version. Experimental and Clinical Gastroenterology 2021; 1(1) doi: 10.31146/1682-8658-ecg-185-1-4-52
207	Abdelilah Arredouani. Lifestyle-Related Diseases and Metabolic Syndrome. 2022; doi: 10.5772/intechopen.106445
208	Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway. Journal of Proteome Research 2020; 19(7) doi: 10.1021/acs.jproteome.9b00405
209	Mohammad Yassin Zamanian, Mehraveh Sadeghi Ivraghi, Lusine G. Khachatryan, Diana E. Vadiyan, Hanie Yavarpour Bali, Maryam Golmohammadi. A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation. Food Science & Nutrition 2023; 11(12) doi: 10.1002/fsn3.3713
210	Andrea Lund, Uffe Kjaergaard, Lotte Bertelsen, Esben Søvsø Hansen, Katrine Holm Andersen, Steffen Ringgaard, Jens Randel Nyengaard, Christoffer Laustsen, Frank Viborg Mortensen. Assessment of hepatic steatosis during rat liver regeneration after 70% partial hepatectomy using stereology and MRI-PDFF. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-27716-0
211	Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
212	Emily Brown, T. Hydes, A. Hamid, D.J. Cuthbertson. Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. Clinical Therapeutics 2021; 43(9) doi: 10.1016/j.clinthera.2021.07.013
213	Farqad Abdulqader, Lennex Yu, Mark H. Vickers, Elwyn C. Firth, Sue R. McGlashan. Voluntary physical activity in early life attenuates markers of fatty liver disease in adult male rats fed a high-fat diet. British Journal of Nutrition 2023; 129(10) doi: 10.1017/S0007114522002562
214	Mohamed Abdel-Samiee, Essam Salah Ibrahim, Mohamed Kohla, Eman Abdelsameea, Mohsen Salama. Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics 2024; 15(6): 97381 doi: 10.4292/wjgpt.v15.i6.97381 Abstract(502) \| Core Tip(611) \| Full Article(HTML)(2278) \| Full Article (PDF)-450K(193) \| Full Article with Cover (PDF)-1283K(254) \| Full Article (XML)-198K(120) \| Audio-1786K(20) \| Peer-Review Report-224K(116) \| Answering Reviewers-601K(129) \| Times Cited (0) \| Total Visits (3367) \| Open
215	Chang Ge, Yi Yuan, Xiaoning Li, Jianmin Zhang, Jitao Ling, Xuehong Zheng, Yuting Wu, Xin Huang, Pingping Yang, Xiao Liu, Deju Zhang, Jianping Liu, Jing Zhang, Peng Yu. Advances in understanding the mechanism of noncoding RNA (ncRNA)-mediated regulation of macrophage polarization in NAFLD. Biochemical Pharmacology 2025; 242 doi: 10.1016/j.bcp.2025.117372
216	Xiao Sun, Xinlei Wang, Lili Fu, Xiaoyan Wang, Lingxin Chen, Yan Huang. A Nanofluorescent Probe for Evaluating the Fluctuation of Aminopeptidase N in Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis. Analytical Chemistry 2024; 96(36) doi: 10.1021/acs.analchem.4c03298
217	Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers 2021; 13(4) doi: 10.3390/cancers13040790
218	Ludovico Abenavoli, Luigi Boccuto, Alessandro Federico, Marcello Dallio, Carmelina Loguercio, Laura Di Renzo, Antonino De Lorenzo. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. International Journal of Environmental Research and Public Health 2019; 16(17) doi: 10.3390/ijerph16173011
219	Sara Karjoo, Anthony Auriemma, Teresa Fraker, Harold Edward Bays. Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2022; 3 doi: 10.1016/j.obpill.2022.100027
220	Albine Djeagou, Kavyasri Gunukula, Anas Sermani, Sai Kiran Vaspari. Emerging Perspectives in the Diagnosis and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Narrative Review. Cureus 2025; doi: 10.7759/cureus.95288
221	Ridhi Deo, Suranjan Panigrahi. Explainability Analysis of Black Box SVM models for Hepatic Steatosis Screening. 2022 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT) 2022; doi: 10.1109/HI-POCT54491.2022.9744067
222	Khara Lucius. Nutritional and Botanical Approaches for Nonalcoholic Fatty Liver Disease. Alternative and Complementary Therapies 2020; 26(6) doi: 10.1089/act.2020.29303.klu
223	Ahmed Hashem, Yogesh Shastri, Malfi Al Otaibi, Elwin Buchel, Hussam Saleh, Reyaz Ahmad, Hamouda Ahmed, Fateh Al Idris, Saleh Ahmed, Mohamed Guda, Anton Gillessen. Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of Silymarin. Gastroenterology Insights 2021; 12(2) doi: 10.3390/gastroent12020014
224	Keyur Patel, Diego Moreno Baca, Natalia Konstantelos, Ginnie Ng, Urja Lathia. Cardiometabolic comorbidity and health outcomes of persons with metabolic dysfunction–associated steatotic liver disease (MASLD) in Ontario, Canada. Canadian Liver Journal 2026; doi: 10.3138/canlivj-2026-0020
225	Arshad Mehmood, Lei Zhao, Yong Wang, Fei Pan, Shuai Hao, Huimin Zhang, Asra Iftikhar, Muhammad Usman. Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review. Food Research International 2021; 142 doi: 10.1016/j.foodres.2021.110180
226	Fangfei Xie, Yuyu Pei, Quan Zhou, Deli Cao, Yun Wang. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01560-3
227	Shuangzhen Jia, Yuzhen Zhao, Jiaqi Liu, Xu Guo, Moxian Chen, Shaoming Zhou, Jianli Zhou. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy. Frontiers in Pediatrics 2022; 9 doi: 10.3389/fped.2021.784221
228	Ana Jimenez-Pastor, David Marti-Aguado, Bernardo Pereira, Clara Alfaro-Cervello, Alexandre Perez-Girbes, Angel Alberich-Bayarri, Luis Marti-Bonmati. Impact of hepatic vessels on whole liver proton density fat fraction and R2* quantification. European Radiology Experimental 2026; 10(1) doi: 10.1186/s41747-025-00663-1
229	Dmitry I. Darenskiy. Features of the development and treatment of lipid metabolism disorders in patients with metabolic dysfunction-associated steatotic liver disease: A review. Consilium Medicum 2025; 27(10) doi: 10.26442/20751753.2025.10.203461
230	Nuojin Guo, Hekai Shi, Hao Zhang, Hua Wang. Comparison of the efficacy and safety of hypoglycemic treatments in patients with non-alcoholic fatty liver disease and type-2 diabetes: a systematic review and Bayesian network analysis. European Journal of Clinical Pharmacology 2023; 79(11) doi: 10.1007/s00228-023-03561-w
231	Ruojia Ma, Yike Zhan, Yamei Zhang, Liangan Wu, Xing Wang, Ming Guo. Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic mice. Drug Development Research 2021; doi: 10.1002/ddr.21905
232	Laya Hooshmand Gharabagh, Ali Shargh, Mohammad Reza Mohammad Hosseini Azar, Ayda Esmaeili. Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease. Clinics and Research in Hepatology and Gastroenterology 2024; 48(3) doi: 10.1016/j.clinre.2023.102279
233	Oh Young Kwon, Mi Kyung Lee, Hye Won Lee, Hyerang Kim, Jae Seung Lee, Yeonsoo Jang. Mobile App–Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial. Journal of Medical Internet Research 2024; 26 doi: 10.2196/49839
234	Jörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, Elisabetta Bugianesi, Branko Popovic. Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review. Expert Review of Gastroenterology & Hepatology 2021; 15(11) doi: 10.1080/17474124.2021.1974295
235	Dominic S. Ng. Emerging insight into the role of cellular cholesterol in the pathogenesis of nonalcoholic steatohepatitis progression. Current Opinion in Lipidology 2020; 31(4) doi: 10.1097/MOL.0000000000000693
236	Melese Alemnew Ayal, Yeshiwas Admasu Dessie, Meskerem Eshetie Nega, Woynshet Tsegaw Negash, Senait Mulat Berihun. Treatment outcomes of chronic liver disease and associated factors among patients treated at hospitals in Bahir Dar city, north-west Ethiopia. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03719-z
237	David Brain, Amarzaya Jadambaa, Sanjeewa Kularatna. Methodology to derive preference for health screening programmes using discrete choice experiments: a scoping review. BMC Health Services Research 2022; 22(1) doi: 10.1186/s12913-022-08464-7
238	Yuling Song, Boru Chen, Lu Jiang, Fangkun Zhao, Xiuqin Feng. Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric and Mapping Analysis. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(5) doi: 10.2174/0118715303230418230925060312
239	Harold E. Bays, Amit Khera, Michael J. Blaha, Matthew J Budoff, Peter P. Toth. Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”). American Journal of Preventive Cardiology 2021; 6 doi: 10.1016/j.ajpc.2021.100176
240	Natalia O. Nosko, Viacheslav V. Kharchenko. INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE. Wiadomości Lekarskie 2021; 74(10) doi: 10.36740/WLek202110212
241	Zhixin Zhang, Jiahui Wang, Yan Lin, Juan Chen, Jian Liu, Xian Zhang. Nutritional activities of luteolin in obesity and associated metabolic diseases: an eye on adipose tissues. Critical Reviews in Food Science and Nutrition 2024; 64(12) doi: 10.1080/10408398.2022.2138257
242	Josephine Skat-Rørdam, Kamilla Pedersen, Gry Freja Skovsted, Ida Gregersen, Sara Vangsgaard, David H. Ipsen, Markus Latta, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea Pig. Antioxidants 2021; 11(1) doi: 10.3390/antiox11010069
243	Annamaria Sila, Sara De Nucci, Caterina Bonfiglio, Vincenza Di Stasi, Nicole Cerabino, Martina Di Chito, Roberta Rinaldi, Paola Cantalice, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Nicoletta Maria Tutino, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity. Nutrients 2024; 16(6) doi: 10.3390/nu16060874
244	Галина Корнован , Володимир Синенко , Лариса Колотвіна , Яна Бажора , Дарʼя Лагода , Вероніка Назарян , Ганна Амірова , Олена Паслар . КОМОРБІДНА ПАТОЛОГІЯ ПЕЧІНКИ У ПАЦІЄНТІВ, ЯКІ ЖИВУТЬ З ОЖИРІННЯМ. Grail of Science 2022; (17) doi: 10.36074/grail-of-science.22.07.2022.073
245	Fangzhi Yue, Ying Shi, Shanyu Wu, Lin Xing, Dan He, Lin Wei, Anqi Qiu, Ryan Russell, Dongmei Zhang. Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD. iScience 2023; 26(12) doi: 10.1016/j.isci.2023.108560
246	Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies. F1000Research 2022; 11 doi: 10.12688/f1000research.109134.1
247	Rui Tavares, Mireia Alemany-Pagès, Sara Araújo, Neil Cohn, João Ramalho-Santos, Anabela Marisa Azul. Comics in Science and Health Communication: Insights From Mutual Collaboration and Framing a Research Practice. International Journal of Qualitative Methods 2023; 22 doi: 10.1177/16094069231183118
248	Di Wang, Bing-Yan Zhou, Lei Xiang, Xu-Yong Chen, Jie-Xiong Feng. Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(25): 3132-3139 doi: 10.3748/wjg.v30.i25.3132 Abstract(774) \| Core Tip(830) \| Full Article(HTML)(3753) \| Full Article (PDF)-408K(264) \| Full Article with Cover (PDF)-880K(181) \| Full Article (XML)-131K(149) \| Audio-397K(21) \| Peer-Review Report-199K(130) \| Answering Reviewers-110K(134) \| Times Cited (9) \| Total Visits (4347) \| Open
249	Marco Arrese, Francisco Barrera, Nicolas Triantafilo, Juan Pablo Arab. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations. Expert Review of Gastroenterology & Hepatology 2019; 13(9) doi: 10.1080/17474124.2019.1649981
250	Robert Beaumont Wilson, Yicong Liang, Devesh Kaushal, Anitra Carr. Molecular Pharmacology of Vitamin C and Relevance to Health and Obesity—A Narrative Review. International Journal of Molecular Sciences 2024; 25(14) doi: 10.3390/ijms25147523
251	T. N. Alexandrova, O. Ya. Babak . Effects of Ademetionine on Liver Fibrosis, Level of Pentraxin-3 and Metabolic Indicators in Patients with Comorbid Course of Non-alcoholic Liver Disease and Arterial Hypertension. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2020; 5(6) doi: 10.26693/jmbs05.06.095
252	Chayanis Kositamongkol, Sukrit Kanchanasurakit, Chiraphong Auttamalang, Nutkamon Inchai, Thanatchaporn Kabkaew, Sarunporn Kitpark, Nathorn Chaiyakunapruk, Acharaporn Duangjai, Surasak Saokaew, Pochamana Phisalprapa. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.786596
253	David Hermanus Wessels, Zeil Rosenberg. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?. World Journal of Hepatology 2021; 13(2): 233-241 doi: 10.4254/wjh.v13.i2.233 Abstract(1286) \| Core Tip(1286) \| Full Article(HTML)(3671) \| Full Article (PDF)-1946K(478) \| Full Article (Word)-228K(332) \| Audio-910K(5) \| Peer-Review Report-230K(341) \| Answering Reviewers-55K(264) \| Times Cited (15) \| Total Visits (6014) \| Open
254	Asha Tiwari, Ekta Rao, Iswarya Suresh, Manish Tiwari, Ravindra Kumar. Hepatobiliary Manifestations in Thalassemia Patients: A Narrative Review. Hemoglobin 2025; 49(3) doi: 10.1080/03630269.2025.2493946
255	Sina Ghandian, Rahul Thapa, Anurag Garikipati, Gina Barnes, Abigail Green‐Saxena, Jacob Calvert, Qingqing Mao, Ritankar Das. Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis. JGH Open 2022; 6(3) doi: 10.1002/jgh3.12716
256	Antoni Sureda, Margalida Monserrat-Mesquida. Omega-3 Fatty Acids. 2025; doi: 10.1007/978-3-031-84200-9_9
257	Manouchehr Khoshbaten, Samineh Beheshtirouy, Shahrzad Shayanrad, Afshin Gharekhani, Haleh Rezaee. Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial. Drug Research 2023; 73(04) doi: 10.1055/a-1997-0401
258	Dimitrios A. Koutoukidis, Sandi Yen, Paula Gomez Castro, Mariya Misheva, Susan A. Jebb, Paul Aveyard, Jeremy W. Tomlinson, Ferenc E. Mozes, Jeremy F. Cobbold, Jethro S. Johnson, Julian R. Marchesi. Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2392864
259	Kamil Synoradzki, Paweł Grieb. Citicoline: A Superior Form of Choline?. Nutrients 2019; 11(7) doi: 10.3390/nu11071569
260	Zhuo Wei, Dan Zhao, Ye Zhang, Yuanli Chen, Shuang Zhang, Qi Li, Peng Zeng, Xiaoju Li, Wenwen Zhang, Yajun Duan, Jihong Han, Xiaoxiao Yang. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner. Biochemical and Biophysical Research Communications 2019; 519(4) doi: 10.1016/j.bbrc.2019.09.084
261	Manouchehr Khoshbaten, Elnaz Shaseb, Samineh Beheshtirouy, Ali Hossainzadeh, Haleh Rezaee. Efficacy of metformin versus l‐carnitine in vitamin E‐treated patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial. Advances in Digestive Medicine 2025; 12(3) doi: 10.1002/aid2.13428
262	Mohammad El-Nablaway, Mohamed Adel, Eslam Kamal Fahmy, Hossameldin Abouhish, Amal Fahmy Dawood, Mamdouh Eldesoqui. Metformin mitigates metabolic dysfunction-associated steatohepatitis in rats by altering steatosis-related micro-RNAs and Aquaporin-9. Journal of Molecular Histology 2026; 57(1) doi: 10.1007/s10735-025-10681-3
263	Wenfeng Ding, Lanlan Liu, Wenjing Lu, Yingli Li, Jing Zhang, Cui Zhang, Yufei Wang, Xueping Ma, Xiaoli Yang. Development of a Fatty Liver Index Based on Real‐World Data. iLABMED 2025; 3(1) doi: 10.1002/ila2.75
264	Jae-Hyung Roh, Hanbyul Lee, Bae Yun-Jeong, Chan Sun Park, Hyo-Jung Kim, Sun-Young Yoon, Huei-Kai Huang. A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults. PLOS ONE 2022; 17(1) doi: 10.1371/journal.pone.0262715
265	Somaya Albhaisi. Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?. European Medical Journal 2019; doi: 10.33590/emj/10310531
266	Hideyuki Tamai, Jumpei Okamura, Kishio Nanjo. Moderate‐carbohydrate diet without caloric or lipid restriction for Japanese adult patients with nonalcoholic fatty liver disease: A prospective cohort study. Hepatology Research 2023; 53(12) doi: 10.1111/hepr.13954
267	Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2) doi: 10.1111/apt.15575
268	Di Cao, Mengyi Li, Yang Liu, He Jin, Dawei Yang, Hui Xu, Han Lv, JIa Liu, Peng Zhang, Zhongtao Zhang, Zhenghan Yang. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00821-6
269	Cai-yan Zou, Yan Sun, Jun Liang. Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,. Clinics and Research in Hepatology and Gastroenterology 2023; 47(1) doi: 10.1016/j.clinre.2022.102053
270	Èlia Navarro-Masip, Nuria Mestres Petit, Blanca Salinas-Roca , Fernando Herrerías, Felip Vilardell, Mari Cruz de la Fuente, Judit Pallares, Maite Santamaría, Marta Zorzano-Martínez, Enric Sánchez , Xavier Matías-Guiu , Carolina López-Cano, Ana Gloria Soler, Josep León-Mengíbar, Marta Bueno, Albert Lecube. Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver®) Diagnoses. Obesity Facts 2024; 17(5) doi: 10.1159/000538765
271	Laura Comi, Claudia Giglione, Fationa Tolaj Klinaku, Federico Pialorsi, Valentina Tollemeto, Maria Zurlo, Antonio Seneci, Paolo Magni. Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities. Food Frontiers 2025; 6(2) doi: 10.1002/fft2.535
272	Dóra Mátis, Péter Hegyi, Brigitta Teutsch, Tamás Tornai, Bálint Erőss, Gabriella Pár, Szilárd Váncsa. Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1114836
273	Bitasta Mandal, Rakesh Das, Sandip Mondal. Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease. Annales Pharmaceutiques Françaises 2024; 82(3) doi: 10.1016/j.pharma.2024.02.005
274	Sayed Mohammad Hosseeini, Mohammad Jafari, Marzieh Tahmasebi, Payman Adibi. Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province. International Journal of Preventive Medicine 2024; 15 doi: 10.4103/ijpvm.ijpvm_284_22
275	John A. Dougherty, Erenie Guirguis, Krisy-Ann Thornby. A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease. Annals of Pharmacotherapy 2021; 55(1) doi: 10.1177/1060028020935105
276	Mary P. Moore, Rory P. Cunningham, Rachel A. H. Davis, Sarah E. Deemer, Brandon M. Roberts, Eric P. Plaisance, R. Scott Rector. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(4) doi: 10.1152/ajpgi.00259.2020
277	M. Zhang, W.J. Tu, Q. Zhang, X.L. Wu, X.Y. Zou, S. Jiang. Osteocalcin reduces fat accumulation and inflammatory reaction by inhibiting ROS-JNK signal pathway in chicken embryonic hepatocytes. Poultry Science 2022; 101(11) doi: 10.1016/j.psj.2022.102026
278	Wen Fan, Kairui Tang, Yuanjun Deng, Chuiyang Zheng, Maoxing Pan, Dajin Pi, Zheng Liang, Jianwei Zhen, Qinhe Yang, Yupei Zhang. Bifidobacterium lactis Probio‐M8 prevents nonalcoholic fatty liver disease in high‐fat diet‐fed rats: The potential role in modulating gut microbiota. Food Bioengineering 2024; 3(1) doi: 10.1002/fbe2.12076
279	Zhaowei Dong, Jingjing Yang, Maoying Tian, Xi Wang, Xiaoyan Qin, Qinwan Huang, Jin Wang. Mechanism of Bile‐Processed Coptidis Rhizoma to Treat Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Based on UPLC‐Q‐TOF/MS and Network Pharmacology. ChemistrySelect 2023; 8(13) doi: 10.1002/slct.202204236
280	Jinyun Li, Lu Fang, Miaocui Xi, Anyu Ni, Qiuhui Qian, Zejun Wang, Huili Wang, Jin Yan. Toxic effects of triclosan on hepatic and intestinal lipid accumulation in zebrafish via regulation of m6A-RNA methylation. Aquatic Toxicology 2024; 269 doi: 10.1016/j.aquatox.2024.106884
281	Nonalcoholic Steatohepatitis: Case-Based Focused on Pediatric and Adult Guidelines. Osteopathic Family Physician 2021; 13(2) doi: 10.33181/13024
282	Virendra C. Patil, Aniket Pathade, Ashish Bhagat, Harsha Virendra Patil, Shivamsh R. Kasireddy. Non-Alcoholic Fatty Liver Disease (NAFLD) in Subjects with Metabolic Syndrome. Journal of Datta Meghe Institute of Medical Sciences University 2026; 21(1) doi: 10.4103/jdmimsu.jdmimsu_646_24
283	Karolina Grąt, Michał Grąt, Olgierd Rowiński. Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2020; 8(9) doi: 10.3390/biomedicines8090298
284	Implementing the Mediterranean Diet. 2022; doi: 10.1002/9781119826743.ch13
285	Peyda Korhan, Ezgi Bağırsakçı, Yasemin Öztemur Islakoğlu, Gülhas Solmaz, Burcu Sarıkaya, Deniz Nart, Funda Yılmaz, Neşe Atabey. MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma. Hepatoma Research 2024; doi: 10.20517/2394-5079.2023.140
286	Kim Sui Wan, Halizah Mat Rifin, Muhammad Fadhli Mohd Yusoff, Kishwen Kanna Yoga Ratnam, Wah Kheong Chan, Masni Mohamad, Nurain Mohd Noor, Feisul Mustapha, Noor Ani Ahmad. Prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease in Malaysia 2023: study protocol for a community-based nationwide cross-sectional survey. BMJ Open 2023; 13(10) doi: 10.1136/bmjopen-2023-074432
287	Chiara Zusi, Alessandro Mantovani, Francesca Olivieri, Anita Morandi, Massimiliano Corradi, Emanuele Miraglia Del Giudice, Marco Dauriz, Luca Valenti, Christopher D. Byrne, Giovanni Targher, Claudio Maffeis. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents. Digestive and Liver Disease 2019; 51(11) doi: 10.1016/j.dld.2019.05.029
288	Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A. A. Abdel‐Ghany, Mohamed O. Mahmoud. Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway. Archiv der Pharmazie 2024; 357(4) doi: 10.1002/ardp.202300631
289	Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(16) doi: 10.3390/ijms21165888
290	Dóra Mátis, Brigitta Teutsch, Szilárd Váncsa. Improved body composition is associated with reduced steatosis in non-alcoholic fatty liver disease, a systematic review and meta-analysis of longitudinal studies. Bulletin of Medical Sciences 2022; 95(1) doi: 10.2478/orvtudert-2022-0006
291	J.M. Carrascosa, E. Vilarrasa, I. Belinchón, P. Herranz, J. Crespo, F. Guimerá, A. Olveira. [Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts. Actas Dermo-Sifiliográficas 2023; 114(5) doi: 10.1016/j.ad.2023.04.013
292	Da Hyun Lee, Jai J. Jee, Yu Seol Lee, Da Ye Kim, Ji Yun Bang, Hye Won Lee, Hong Koh, Soo Han Bae. Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH. Digestive and Liver Disease 2023; 55(11) doi: 10.1016/j.dld.2023.06.015
293	Stefano Ciardullo, Tommaso Monti, Gianluca Perseghin. Lack of awareness of liver organ damage in patients with type 2 diabetes. Acta Diabetologica 2021; 58(5) doi: 10.1007/s00592-021-01677-y
294	Alessio Aghemo, Olga P. Alekseeva, Francesco Angelico, Igor G. Bakulin, Natalia V. Bakulina, Dmitry Bordin, Alexey O. Bueverov, Oxana M. Drapkina, Anton Gillessen, Elvira M. Kagarmanova, Natalia V. Korochanskaya, U. A. Kucheryavii, Leonid B. Lazebnik, Maria A. Livzan, Igor V. Maev, Anatolii I. Martynov, Marina F. Osipenko, Evgenii I. Sas, Antonina Starodubova, Yurii P. Uspensky, Elena V. Vinnitskaya, Emilia P. Yakovenko, Alexey A. Yakovlev. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review. Annals of Medicine 2022; 54(1) doi: 10.1080/07853890.2022.2069854
295	Yu Zhu, Hu Yang, Shaoxian Liang, Honghua Zhang, Yufeng Mo, Songxian Rao, Yaozong Zhang, Zhuang Zhang, Weiqiang Wang, Wanshui Yang. Higher Adherence to Healthy Lifestyle Score Is Associated with Lower Odds of Non-Alcoholic Fatty Liver Disease. Nutrients 2022; 14(21) doi: 10.3390/nu14214462
296	Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica (English Edition) 2022; 158(11) doi: 10.1016/j.medcle.2022.05.009
297	Lvying Wu, Lei Xing, Yake Zou, Zichen Wang, Yuanyuan Gou, Lei Zhang, Su Guan. UPLC-QTOF-MS Based Comparison of Rotundic Acid Metabolic Profiles in Normal and NAFLD Rats. Metabolites 2022; 13(1) doi: 10.3390/metabo13010038
298	Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Emanuela Zappulo, Riccardo Scotto, Biagio Pinchera, Ivan Gentile. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi. Reviews on Recent Clinical Trials 2019; 14(2) doi: 10.2174/1574887114666181204102516
299	Syed Shah Mohammed Faiyaz, Mubashir Zafar, S. Alharbi Meshal Jameel, Fahad Munawir G Alharbi, Alshaymaa Alameen Sayed Alameen, Syed Monowar Alam Shahid. Assessing Knowledge, Attitudes, and Factors Influencing Nonalcoholic Fatty Liver Disease among Adults in Saudi Arabia. Asian Journal of Pharmaceutical Research and Health Care 2025; 17(1) doi: 10.4103/ajprhc.ajprhc_36_25
300	Yurou Xu, Youyi Wang, Qi Zhao, Bo Chen, Na Wang, Tiejun Zhang, Yonggen Jiang, Yiling Wu, Na He, Genming Zhao, Xing Liu. Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population. Hepatology International 2024; 18(2) doi: 10.1007/s12072-024-10638-w
301	Vahid Sheikhi, Zahra Heidari. Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Advanced Biomedical Research 2022; 11(1) doi: 10.4103/abr.abr_15_21
302	Jinchunzi Yang, Elisa Félix-Soriano, Alejandro Martínez-Gayo, Javier Ibañez-Santos, Neira Sáinz, J Alfredo Martínez, María J. Moreno-Aliaga. SIRT1 and FOXO1 role on MASLD risk: effects of DHA-rich n-3 PUFA supplementation and exercise in aged obese female mice and in post-menopausal overweight/obese women. Journal of Physiology and Biochemistry 2024; 80(3) doi: 10.1007/s13105-024-01044-9
303	Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver. Journal of the Chinese Medical Association 2021; 84(9) doi: 10.1097/JCMA.0000000000000585
304	Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M. Ashworth Dirac, Sven Francque, Jacob George, Hannes Hagström, Terry T.-K. Huang, Mona H. Ismail, Achim Kautz, Shiv Kumar Sarin, Rohit Loomba, Veronica Miller, Philip N. Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero-Gómez, Jörn M. Schattenberg, Emmanuel A. Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M. Younossi, Shira Zelber-Sagi, Fredrik Åberg, Leon Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramon Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourliere, Radan Bruha, Elisabetta Bugianesi, Patrizia Burra, Maria Buti, Christopher D. Byrne, Jose Luis Calleja, Patrizia Carrieri, Flloyd Carter, Marlen Ivon Castellanos Fernandez, Gabriela Castillo-Lopez, Graciela E. Castro-Narro, Henry Lik Yuen Chan, Wah-Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen Corey, Antonio Craxi, Donna Cryer, Anuradha Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Ledinghen, Stefano DelPrato, Alessandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El Kassas, Osama M. Elsanousi, Gamal Esmat, Jian-Gao Fan, Nathalie Farpour-Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino A. Gani, Lynn Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon-Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch, Ingrid J. Hickman, Samantha L. Hocking, Bela Hunyady, Ramazan Idilman, Vasily A. Isakov, Mohammad H. Jamal, Peter Jepsen, Natacha Jreige Iskandar, Myeong Jun Song, K. C. Sudhamshu, Satoru Kakizaki, George Kalamitsis, Fasiha Kanwal, Jia-Horng Kao, Lee Kaplan, Takumi Kawaguchi, Yousef Khader, Seung Up Kim, Nicolas Kodjoh, Ger Koek, Kazuhiko Koike, Narcisse Patrice Komas, Marko Korenjak, Marcelo Kugelmas, Asma Labidi, Naomi F. Lange, Joel E. Lavine, Mariana Lazo, Nancy Lee, Cosmas Rinaldi A. Lesmana, Chun-Jen Liu, Michelle T. Long, Patricio Lopez-Jaramillo, Reza Malekzadeh, Mamun Al Mahtab, Giulio Marchesini, Rui Marinho, Sophia E. Martínez Vázquez, Lyudmila Mateva, Charles Mbendi Nlombi, Pascal Melin, Ivana Mikolasevic, Tamara Milovanovic, Carla Musso, Atsushi Nakajima, Edna Nava, Alexander V. Nersesov, Dafina Nikolova, Suzanne Norris, Katja Novak, Jude Oben, Janus P. Ong, Charles Onyekwere, George Papatheodoridis, Imran Paruk, Keyur Patel, M. Paula Macedo, Carlos Penha-Gonçalves, Marlene Pérez Figueroa, Wolf Peter Hofmann, Salvatore Petta, Claudia Pinto Marques Souza de Oliveira, Puneet Puri, Calvin Q. Pan, Marek Rac, Johanna Ralston, Alnoor Ramji, Homie Razavi, Mario Reis Alvares-da-Silva, Stuart Roberts, Michael Roden, Tamsin Rose, Samir Rouabhia, Patrizia Rovere-Querini, Ian A. Rowe, Shakhlo Sadirova, Riina Salupere, Tobokalova Saparbu, Raymond Sayegh, Giada Sebastiani, Yosuke Seki, Josefina Selmo, Abdel Karim Serme, Jonathan E. Shaw, Thrivikrama Shenoy, Nick Sheron, Oren Shibolet, Marcelo Silva, Igor Skrypnyk, Piotr Socha, Joan Soriano, C. Wendy Spearman, Kannan Sridharan, Juan José Suárez, Dhastagir Sultan Sheriff, Ki-Chul Sung, Mark Swain, Frank Tacke, Shahrad Taheri, Soek-Siam Tan, Elliot B. Tapper, Hannele Yki-Järvinen, Maja Thiele, Isaac Thom Shawa, Ieva Tolmane, Esther A. Torres, Michael Trauner, Sombat Treeprasertsuk, Adela Turcanu, Jonas Valantinas, Mette Vesterhus, Imam Waked, Sarah H. Wild, Jose Willemse, Robert J. Wong, Stavra Xanthakos, Dan Yock Young, Ming-Lung Yu, Kenneth I. Zheng, Mudjat Zeybel, Ming-Hua Zheng. Advancing the global public health agenda for NAFLD: a consensus statement. Nature Reviews Gastroenterology & Hepatology 2022; 19(1) doi: 10.1038/s41575-021-00523-4
305	Ewa Garbiec, Judyta Cielecka-Piontek, Magdalena Kowalówka, Magdalena Hołubiec, Przemysław Zalewski. Genistein—Opportunities Related to an Interesting Molecule of Natural Origin. Molecules 2022; 27(3) doi: 10.3390/molecules27030815
306	Halyna Kuznietsova, Oksana Lynchak, Natalia Dziubenko, Tetyana Herheliuk, Yuriy Prylutskyy, Volodymyr Rybalchenko, Uwe Ritter. Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injury. BioImpacts 2019; 9(4) doi: 10.15171/bi.2019.28
307	Sara De Nucci, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Martina Di Chito, Roberta Rinaldi, Vito Giannuzzi, Raffaele Cozzolongo, Giuseppina Piazzolla, Gianluigi Giannelli, Rodolfo Sardone, Giovanni De Pergola. Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1002669
308	Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?. Nutrients 2019; 11(12) doi: 10.3390/nu11122878
309	Mélanie Maltais, Diane Brisson, Daniel Gaudet. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia. Journal of Clinical Medicine 2021; 10(4) doi: 10.3390/jcm10040669
310	Amélio F. Godoy-Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, João Marcello de Araujo-Neto, Marcello Casaccia Bertoluci. 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01259-2
311	Chukwuebuka Joseph Ejiyi, Dongsheng Cai, Makuachukwu B. Ejiyi, Ijeoma A. Chikwendu, Kenneth Coker, Ariyo Oluwasanmi, Oluwatoyosi F. Bamisile, Thomas U. Ejiyi, Zhen Qin. Polynomial-SHAP analysis of liver disease markers for capturing of complex feature interactions in machine learning models. Computers in Biology and Medicine 2024; 182 doi: 10.1016/j.compbiomed.2024.109168
312	Sandra A. Soto‐Alarcón, Macarena Ortiz, Paula Orellana, Francisca Echeverría, Andrés Bustamante, Alejandra Espinosa, Paola Illesca, Daniel Gonzalez‐Mañán, Rodrigo Valenzuela, Luis A. Videla. Docosahexaenoic acid and hydroxytyrosol co‐administration fully prevents liver steatosis and related parameters in mice subjected to high‐fat diet: A molecular approach. BioFactors 2019; 45(6) doi: 10.1002/biof.1556
313	Rodrigo M Carrillo-Larco, Wilmer Cristobal Guzman-Vilca, Manuel Castillo-Cara, Claudia Alvizuri-Gómez, Saleh Alqahtani, Vanessa Garcia-Larsen. Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III. BMJ Open 2022; 12(11) doi: 10.1136/bmjopen-2022-067203
314	Stergios A. Polyzos, Dimitrios G. Goulis, Olga Giouleme, Georgios S. Germanidis, Antonis Goulas. Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease. Current Obesity Reports 2022; 11(3) doi: 10.1007/s13679-022-00474-0
315	Ricard Corcelles, Juan S. Barajas-Gamboa, Joana Ferrer-Fàbrega, Matthew Kroh. Bariatric surgery in liver transplant: Current trends and future perspectives. Cirugía Española (English Edition) 2022; 100(2) doi: 10.1016/j.cireng.2021.04.021
316	Danyan Ma, Jinyang Zeng, Bingkun Huang, Fangfang Yan, Jiawen Ye, Yun Chen, Xiying Zeng, Xin Zheng, Fangsen Xiao, Mingzhu Lin, Changqin Liu, Zhibin Li. Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02011-0
317	Abdulrahman Ismaiel, Ayman Jaaouani, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis. Biomedicines 2021; 9(12) doi: 10.3390/biomedicines9121890
318	Xiaoyan Zhang, Jingxin Li, Tiancai Liu, Min Zhao, Baozhu Liang, Hong Chen, Zhen Zhang, Ihtisham Bukhari. Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery. Disease Markers 2022; 2022 doi: 10.1155/2022/4369329
319	Mengqing Zhang, Chengcheng Guo, Zonglin Li, Xiaoling Cai, Xin Wen, Fang Lv, Chu Lin, Linong Ji. Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1α/PPARα and KEAP1/NRF2 Pathways. Pharmaceuticals 2024; 17(10) doi: 10.3390/ph17101287
320	Ryoko Tajima, Fumiaki Imamura, Takeshi Kimura, Satomi Kobayashi, Katsunori Masuda, Kaoruko Iida. Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adults. Clinical Nutrition 2020; 39(5) doi: 10.1016/j.clnu.2019.07.001
321	Anton Gillessen, Francesco Angelico, Jun Chen, Lungen Lu, Maria Isabel Lucena, Qingchun Fu, Qing Xie, Raul J. Andrade, Wen Xie, Xiaoyuan Xu, Yanyan Yu, Yi-min Mao, Yuemin Nan. Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations. Gastro Hep Advances 2022; 1(5) doi: 10.1016/j.gastha.2022.05.006
322	Jai Kumar, Sana Mohsin, Misha Hasan, Abdur Raheem Bilal, Kumail Mustafa Ali, Ahmed Umer, Dua Zehra Mohammad Hadi, Sanjna Nandlal, Sarwan Kumar. Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(1) doi: 10.1016/j.clinre.2023.102261
323	Jane Ha, Sun Young Yim, Raffi Karagozian. Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2023; 21(10) doi: 10.1016/j.cgh.2022.11.019
324	Asia Awad AbdelGader, Afra M. Al Bakry, Hind A. Elnasri, Dawelbiet Abdelaal Yahia, Mona Abdelrahman Mohamed Khaier. Utilizing computational approaches for the prediction of alpha-PPAR inhibitors from baobab (Adansonia digitata) against non-alcoholic fatty liver disease. Academia Molecular Biology and Genomics 2024; 1(1) doi: 10.20935/AcadMolBioGen7475
325	Valentin Metzner, Gloria Herzog, Tobias Heckel, Thorsten Bischler, Julia Hasinger, Christoph Otto, Martin Fassnacht, Andreas Geier, Florian Seyfried, Ulrich Dischinger. Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements. Journal of Clinical Medicine 2022; 11(3) doi: 10.3390/jcm11030753
326	Nicole Cerabino, Caterina Bonfiglio, Leonilde Bonfrate, Pasqua Letizia Pesole, Dolores Stabile, Endrit Shahini, Martina Di Chito, Giovanni De Pergola, Gianluigi Giannelli. Effects of a Bioactive Vegetable-Enriched Diet on Autotaxin and Liver Fibrosis in MASLD with Evidence of Sex-Specific Responses: A Pilot Study. Nutrients 2025; 17(23) doi: 10.3390/nu17233676
327	Keyvan Hejazi, Daniel Hackett. Effect of Exercise on Liver Function and Insulin Resistance Markers in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine 2023; 12(8) doi: 10.3390/jcm12083011
328	Hassan M. Heshmati. Advances in Hepatology. 2021; doi: 10.5772/intechopen.97568
329	Zhiyi Zhang, Jiangyou Li, Jingzi Zeng, Wenhao Wang, Xuzhang Liang, Yuqi Luo, Canjing Chen, Ziqi Luo, Jiangtao He, Danli Kong, Yuanlin Ding. Association between serum methylmalonic acid and metabolic dysfunction-associated steatotic liver disease: NHANES-based study. Medicine 2026; 105(23) doi: 10.1097/MD.0000000000049122
330	Hannah Collins, Grant Beban, John Windsor, Rishi Ram, David Orr, Nicholas Evennett, Benjamin Loveday. Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting. Obesity Surgery 2020; 30(1) doi: 10.1007/s11695-019-04161-3
331	Can Liu, Zeming Bai, Jingmin Cheng. Vitamin E as a Therapeutic Agent for NAFLD: A Systematic Review of Randomized Controlled Trials . American Journal of Internal Medicine 2025; 13(4) doi: 10.11648/j.ajim.20251304.12
332	Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans‐Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon‐Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterology Journal 2022; 10(7) doi: 10.1002/ueg2.12280
333	Vahibe Uluçay Kestane, Murat Baş. Efficacy of the Mediterranean Diet Containing Different Macronutrients on Non-Alcoholic Fatty Liver Disease. Nutrients 2024; 16(16) doi: 10.3390/nu16162699
334	Meng-Yuan Miao, Wen-Wen Han, Jie-Qiong Lyu, Zhong-Yue Liu, Wei Jiang, Zheng Zhang, Zhengbao Zhu, Li-Qiang Qin, Guo-Chong Chen. Female reproductive factors and metabolic dysfunction-associated steatotic liver disease: an integrated analysis of population cohort, liver imaging, and genetic data. American Journal of Obstetrics and Gynecology 2025; 233(5) doi: 10.1016/j.ajog.2025.04.007
335	D. V. Garbuzenko. Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 31(5) doi: 10.22416/1382-4376-2021-31-5-16-24
336	Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(14) doi: 10.3390/jcm10143029
337	Hao Han, Yan Guo, Xiaoyu Li, Dongxing Shi, Tingli Xue, Linqi Wang, Yanyan Li, Mingming Zheng. Plant Sterol Ester of α-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial Biogenesis. Oxidative Medicine and Cellular Longevity 2019; 2019 doi: 10.1155/2019/8294141
338	Mithun Sharma, Madhumita Premkumar, Anand V Kulkarni, Pramod Kumar, D Nageshwar Reddy, Nagaraja Padaki Rao. Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail. Journal of Clinical and Translational Hepatology 2020; 0(000) doi: 10.14218/JCTH.2020.00055
339	Anouk Charlot, Joffrey Zoll. Beneficial Effects of the Ketogenic Diet in Metabolic Syndrome: A Systematic Review. Diabetology 2022; 3(2) doi: 10.3390/diabetology3020020
340	Wangya Jia, Keke Wang, Shaobo Zhang, Wenxu Lu, Ao Du, Jian Li, Lili Ji, Hong Xu. Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease. Phytomedicine 2022; 104 doi: 10.1016/j.phymed.2022.154326
341	MoezAlIslam Faris, Haitham Jahrami, Dana Abdelrahim, Nicola Bragazzi, Ahmed BaHammam. The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression. Diabetes Research and Clinical Practice 2021; 178 doi: 10.1016/j.diabres.2021.108951
342	Kay Craven, Donna Clement, Caroline T. Brewster, Jamie Messenger, Kathryn M. Kolasa. Non-Alcoholic Fatty Liver Disease (NAFLD) and Nutrition. Nutrition Today 2021; 56(6) doi: 10.1097/NT.0000000000000514
343	Julia R. Gips, Lisa Yanek, Jiajun Wu, James P. Hamilton, Tinsay A. Woreta, Jeanne M. Clark. Clinical cohort of nonalcoholic fatty liver disease in a primary care setting. Journal of Family Medicine and Primary Care 2024; 13(8) doi: 10.4103/jfmpc.jfmpc_1769_23
344	Elena-Daniela Grigorescu, Mariana Floria, Cristina Mihaela Lăcătușu, Bogdan Mircea-Mihai, Ioana Creţu, Alina Delia Popa, Alina Onofriescu, Irina M. Jaba, Victoriţa Șorodoc, Alexandr Ceasovschih, Laurenţiu Șorodoc. The Relationship between Hepatic Steatosis, inflammation and insulin Resistance in type 2 Diabetes with Metabolic Imbalance. Internal Medicine 2019; 16(4) doi: 10.2478/inmed-2019-0073
345	Stefano Ciardullo, Gianluca Perseghin. From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction. Metabolism and Target Organ Damage 2024; doi: 10.20517/mtod.2024.39
346	Lorena Fecury Tavares, Mariana Rosa Bernardo, Kalil Orleans Silveira Pinho, Ana Paula Santos Oliveira Brito, Rodrigo Bona Maneschy, Hamilton Cezar Rocha de Garcia. Doença Hepática Gordurosa Não Alcoólica - Diagnóstico e tratamento. Pará Research Medical Journal 2022; 3(2) doi: 10.4322/prmj.2019.011
347	Meng-Hsun Yu, Tung-Wei Hung, Chi-Chih Wang, Sheng-Wen Wu, Tzu-Wei Yang, Ching-Yu Yang, Tsui-Hwa Tseng, Chau-Jong Wang. Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro. International Journal of Molecular Sciences 2021; 22(23) doi: 10.3390/ijms222313163
348	Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J. Sanyal, Anne-Sophie Sejling, Stephen A. Harrison. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. New England Journal of Medicine 2021; 384(12) doi: 10.1056/NEJMoa2028395
349	Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study. European Journal of Nutrition 2021; 60(6) doi: 10.1007/s00394-020-02476-x
350	Satu Korpimäki, Suvi P Rovio, Markus Juonala, Nina Hutri-Kähönen, Terho Lehtimäki, Tomi P Laitinen, Päivi Tossavainen, Eero Jokinen, Britt-Marie Loo, Satu Männistö, Tuija Tammelin, Atte Haarala, Heikki Aatola, Gaber Komar, Jorma Viikari, Olli Raitakari, Mika Kähönen, Katja Pahkala. Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among Finns. The Journal of Clinical Endocrinology & Metabolism 2023; 109(1) doi: 10.1210/clinem/dgad418
351	Marc-Olivier Deguise, Chantal Pileggi, Yves De Repentigny, Ariane Beauvais, Alexandra Tierney, Lucia Chehade, Jean Michaud, Maica Llavero-Hurtado, Douglas Lamont, Abdelmadjid Atrih, Thomas M. Wishart, Thomas H. Gillingwater, Bernard L. Schneider, Mary-Ellen Harper, Simon H. Parson, Rashmi Kothary. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(1) doi: 10.1016/j.jcmgh.2021.01.019
352	Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; doi: 10.2147/DMSO.S300051
353	Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Review of Gastroenterology & Hepatology 2019; 13(7) doi: 10.1080/17474124.2019.1621164
354	Li‐Wei Chen, Mi‐Sio Huang, Yu‐Chiau Shyu, Rong‐Nan Chien. Gamma‐glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community‐based cross‐sectional study. The Kaohsiung Journal of Medical Sciences 2021; 37(9) doi: 10.1002/kjm2.12395
355	Zhen-Shu Liu, Pei-Lin Li, Yu-We Ku, Po-Wen Chen. Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice. Microorganisms 2022; 10(11) doi: 10.3390/microorganisms10112215
356	Allison M. Carroll, Yaron Rotman. Nutrition Literacy Is Not Sufficient to Induce Needed Dietary Changes in Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology 2023; 118(8) doi: 10.14309/ajg.0000000000002182
357	Hasen A. Al-ghamdi, Fayza F. Al Fayez, Abdulhadi I. Bima, Taghreed M. Khawaji, Ayman Z. Elsamanoudy. Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation. Journal of Clinical and Experimental Hepatology 2021; 11(2) doi: 10.1016/j.jceh.2020.07.003
358	Sathish Kumar Perumal, Madan Kumar Arumugam, Natalia A. Osna, Karuna Rasineni, Kusum K. Kharbanda. Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1478542
359	Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, Benedicto Crespo Facorro. Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019; 95 doi: 10.1016/j.pnpbp.2019.109677
360	Fariha Hasan, Avneet Singh, Alexander Garcia, Syeda Hafsa Qadri, Hina Sattar, Rimmel Ali, Hassam Ali, Tommy Nguyen, Babu P. Mohan, Krysta Contino. Evaluating the impact of the Dietary Approaches to Stop Hypertension diet versus a calorie‐restricted diet on metabolic dysfunction‐associated steatotic liver disease: A meta‐analysis of randomized controlled trials. Hepatology Research 2025; 55(4) doi: 10.1111/hepr.14155
361	Lvying Wu, Lei Xing, Yake Zou, Zichen Wang, Yuanyuan Li, Lei Zhang, Su Guan. UPLC-QTOF-MS Based Comparison of Rotundic Acid Metabolic Profiles in Normal and NAFLD Rats. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4005127
362	Ekementeabasi Aniebo Umoh, Agnes Igimi Odey, Condoleezza Bohneji Mbu, Kevin Marshal Otu, Joseph Okon Asuquo, Effiom-ekaha Otu Otu, Victor Kanu Uno, David Oyom Bassey. GC-MS Analysis and ADMET Properties of Tom Brown Weaning Meal and its Subsequent Effect on Liver Enzymes and Learning/Memory Parameters in Male Wistar Rats: A Docking and in Vivo Study. Natural Product Communications 2024; 19(11) doi: 10.1177/1934578X241293663
363	Amir Mari, Tawfik Khoury, Helal Said Ahmad, Fadi Abu Baker, Anas Kadah, Wisam Sbeit, Rinaldo Pellicano, Mahmud Mahamid. The association between non-alcoholic fatty liver disease and valvular heart disease. Minerva Cardioangiologica 2020; 68(1) doi: 10.23736/S0026-4725.19.05087-4
364	Mustafa Al-Karaghouli, Sonia Fuentes, Tracy Davyduke, Mang Ma, Juan G Abraldes. Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD. BMJ Open Gastroenterology 2022; 9(1) doi: 10.1136/bmjgast-2021-000798
365	Haoran Chen, Dongxuan Li, Huimin Zhang, Meiqi Zhang, Yumeng Lin, Haibei He, Aijun Liu, Shiming Shen, Yi Wang, Zhongyu Han. Mechanisms of copper metabolism and cuproptosis: implications for liver diseases. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1633711
366	Wei Wei, Yuhua He, Xiaoxiao Zhang, Yang Wang, Liming Liu. Multi-Omics Investigation Reveals the Therapeutic Effect of Black Ginseng on Copper Deficiency and High-Sugar Induced Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Murine Models. Food Biophysics 2026; 21(1) doi: 10.1007/s11483-026-10108-w
367	Macarena Ortiz, Sandra A. Soto-Alarcón, Paula Orellana, Alejandra Espinosa, Cristian Campos, Sandra López-Arana, Miguel A. Rincón, Paola Illesca, Rodrigo Valenzuela, Luis A. Videla. Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration. Digestive and Liver Disease 2020; 52(8) doi: 10.1016/j.dld.2020.04.019
368	Mohammad H. Jamal, Rawan El-Abd. Laparoscopic Sleeve Gastrectomy. 2021; doi: 10.1007/978-3-030-57373-7_15
369	Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery. Expert Opinion on Investigational Drugs 2020; 29(2) doi: 10.1080/13543784.2020.1721457
370	Chutian Wu, Yun Zhou, Min Wang, Guolin Dai, Xiongxiu Liu, Leizhen Lai, Shaohui Tang. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.772487
371	Hyun-Ji Kim, Eun Bok Baek, Ji-Hee Hwang, Minyoung Lim, Won Hoon Jung, Myung Ae Bae, Hwa-Young Son, Jae-Woo Cho. Application of convolutional neural network for analyzing hepatic fibrosis in mice. Journal of Toxicologic Pathology 2023; 36(1) doi: 10.1293/tox.2022-0066
372	Md. Jahangir Alam, Sanjay K. Banerjee. Biochemistry of Cardiovascular Dysfunction in Obesity. 2020; doi: 10.1007/978-3-030-47336-5_2
373	Huiyan Duan, Minmin Gong, Gang Yuan, Zhi Wang. Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?. Journal of Clinical and Experimental Hepatology 2025; 15(2) doi: 10.1016/j.jceh.2024.102459
374	Pooja Yadav, Khushi Quadri, Renu Kadian, Aafrin Waziri, Pankaj Agrawal, Md Sabir Alam. New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products. iLIVER 2024; 3(4) doi: 10.1016/j.iliver.2024.100131
375	Atilla BEKTAS, Meltem ULUSOY, Kemal DAĞALP. Ursodeoksikolik Asit, Diyabetik Olmayan, Alkol Dışı Karaciğer Yağlanması Tedavisinde Yer Almalı Mı?. Konuralp Tıp Dergisi 2020; 12(1) doi: 10.18521/ktd.527978
376	Wah‐Kheong Chan, Soek‐Siam Tan, Siew‐Pheng Chan, Yeong‐Yeh Lee, Hoi‐Poh Tee, Sanjiv Mahadeva, Khean‐Lee Goh, Anis Safura Ramli, Feisul Mustapha, Nik Ritza Kosai, Raja Affendi Raja Ali. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease. Journal of Gastroenterology and Hepatology 2022; 37(5) doi: 10.1111/jgh.15787
377	Joscha Vonderlin, Triantafyllos Chavakis, Michael Sieweke, Frank Tacke. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis. Cellular and Molecular Gastroenterology and Hepatology 2023; 15(6) doi: 10.1016/j.jcmgh.2023.03.002
378	Gerardo Sarno, Luigi Schiavo, Pietro Calabrese, Ludwig Álvarez Córdova, Evelyn Frias-Toral, Gabriela Cucalón, Eloisa Garcia-Velasquez, Vanessa Fuchs-Tarlovsky, Vincenzo Pilone. The Impact of Bariatric-Surgery-Induced Weight Loss on Patients Undergoing Liver Transplant: A Focus on Metabolism, Pathophysiological Changes, and Outcome in Obese Patients Suffering NAFLD-Related Cirrhosis. Journal of Clinical Medicine 2022; 11(18) doi: 10.3390/jcm11185293
379	Maria Lilibeth Manzanilla Valdez, Maira Rubi Segura Campos. Renal and Hepatic Disease:Cnidoscolus aconitifoliusas Diet Therapy Proposal for Prevention and Treatment. Journal of the American College of Nutrition 2021; 40(7) doi: 10.1080/07315724.2020.1810171
380	Ron S. Newfield, Carrie L. Graves, Robert O. Newbury, Jeffrey B. Schwimmer, James A. Proudfoot, Daphne S. Say, Ariel E. Feldstein. Non‐alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects. Pediatric Diabetes 2018; doi: 10.1111/pedi.12798
381	Qiu-Xuan Li, Han Gao, Yue-Xin Guo, Bo-Ya Wang, Rong-xuan Hua, Lei Gao, Hong-Wei Shang, Xin Lu, Jing-Dong Xu. GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.721198
382	Ralitsa Robeva, Dušan Mladenović, Milena Vesković, Dragan Hrnčić, Jelica Bjekić-Macut, Olivera Stanojlović, Sarantis Livadas, Bulent O. Yildiz, Djuro Macut. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. Maturitas 2021; 151 doi: 10.1016/j.maturitas.2021.06.012
383	Sílvia M. Illamola, Jonathan E. Constance, Angela K. Birnbaum, Catherine M.T. Sherwin. Drug Metabolism in Diseases. 2026; doi: 10.1016/B978-0-443-29289-7.00007-2
384	Yi-Ning Dai, Cheng-Fu Xu, Hong-Ying Pan, Hai-Jun Huang, Mei-Juan Chen, You-Ming Li, Chao-Hui Yu. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease. World Journal of Clinical Cases 2022; 10(13): 4097-4109 doi: 10.12998/wjcc.v10.i13.4097 Abstract(986) \| Core Tip(842) \| Full Article(HTML)(2855) \| Full Article (PDF)-5351K(388) \| Full Article (Word)-2290K(116) \| Audio-1423K(22) \| Peer-Review Report-347K(185) \| Answering Reviewers-78K(188) \| Times Cited (1) \| Total Visits (4424) \| Open
385	Begoña Lavin, Thomas R. Eykyn, Alkystis Phinikaridou, Aline Xavier, Shravan Kumar, Xabier Buqué, Patricia Aspichueta, Carlos Sing‐Long, Marco Arrese, René M. Botnar, Marcelo E. Andia. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. NMR in Biomedicine 2023; 36(8) doi: 10.1002/nbm.4932
386	Maya Margalit, Hanny Yeshua, Neta Gotlieb, Shira Zelber-Sagi. NAFLD and NASH. 2020; doi: 10.1007/978-3-030-37173-9_2
387	Élise Vuille-Lessard, Naomi Lange, Carlotta Riebensahm, Jean-François Dufour, Annalisa Berzigotti. Dietary Interventions in Liver Diseases: Focus on MAFLD and Cirrhosis. Current Hepatology Reports 2021; 20(2) doi: 10.1007/s11901-021-00563-z
388	Weijie Lin, Zhengrong Liu, Ling Li, Zhiling Zhou, Shiyu Ma, Fazhong He. Effects of Shugan Quzhi Capsule in treating different metabolic diseases based on network pharmacology and molecular docking. 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2021; doi: 10.1109/BIBM52615.2021.9669290
389	Samy A. Azer, Rana Hasanato. Use of bile acids as potential markers of liver dysfunction in humans. Medicine 2021; 100(41) doi: 10.1097/MD.0000000000027464
390	Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, George Boon-bee Goh, Simone I. Strasser, Hang Dao Viet, Jia-Horng Kao, Won Kim, Seung Up Kim, Shelley E. Keating, Yusuf Yilmaz, Lubna Kamani, Chia-Chi Wang, Yasser Fouad, Zaigham Abbas, Sombat Treeprasertsuk, Kessarin Thanapirom, Mamun Al Mahtab, Undram Lkhagvaa, Oidov Baatarkhuu, Ashok Kumar Choudhury, Catherine A. M. Stedman, Abhijit Chowdhury, A Kadir Dokmeci, Fu-Sheng Wang, Han-Chieh Lin, Jee-Fu Huang, Jess Howell, Jidong Jia, Mohamed Alboraie, Stuart K. Roberts, Masato Yoneda, Hasmik Ghazinian, Aram Mirijanyan, Yuemin Nan, Cosmas Rinaldi Adithya Lesmana, Leon A. Adams, Gamal Shiha, Manoj Kumar, Necati Örmeci, Lai Wei, George Lau, Masao Omata, Shiv K. Sarin, Jacob George. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatology International 2025; 19(2) doi: 10.1007/s12072-024-10774-3
391	Joanna Michałowska, Ewa Miller-Kasprzak, Paweł Bogdański. Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective. Nutrients 2021; 13(2) doi: 10.3390/nu13020351
392	Amani Al-Shargi, Amal A. El Kholy, Abdulmoneim Adel, Mohamed Hassany, Sara M. Shaheen. Allopurinol versus Febuxostat: A New Approach for the Management of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomedicines 2023; 11(11) doi: 10.3390/biomedicines11113074
393	Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 2021; 11(5) doi: 10.3390/diagnostics11050842
394	Jiu Chen, Siji Wang, Xianyang Xin, Jun Xie. Effects of exercise interventions on metabolic and hepatic function markers in overweight or obese patients with MASLD: a systematic review and meta-analysis. BMC Gastroenterology 2025; 26(1) doi: 10.1186/s12876-025-04517-3
395	Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2022; 41(10) doi: 10.1016/j.clnu.2022.07.003
396	Hao Han, Tingli Xue, Jie Li, Yan Guo, Xiaoyu Li, Linqi Wang, Liyuan Pei, Mingming Zheng. Plant sterol ester of α-linolenic acid improved non-alcoholic fatty liver disease by attenuating endoplasmic reticulum stress-triggered apoptosis via activation of the AMPK. The Journal of Nutritional Biochemistry 2022; 107 doi: 10.1016/j.jnutbio.2022.109072
397	Guoyan Jiang, Chunhong Sun, Xiaodong Wang, Jie Mei, Chen Li, Honghong Zhan, Yixuan Liao, Yongjun Zhu, Jingxin Mao. Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification . Bioengineered 2022; 13(3) doi: 10.1080/21655979.2022.2037374
398	Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes. Biomedicines 2023; 11(10) doi: 10.3390/biomedicines11102611
399	Hüseyin Vural, Ferah Armutcu, Omer Akyol, Ralf Weiskirchen. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clinica Chimica Acta 2021; 523 doi: 10.1016/j.cca.2021.10.018
400	Ji Won Kwak, Yong Jae Lee, Byoungjin Park, Dong Hyuk Jung. Combined effect of serum carcinoembryonic antigen and hepatic steatosis on new-onset ischemic heart disease among middle-aged and older Korean adults: a cohort study. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1275450
401	Ming Li, Qian Wang, Yong Li, Shengtian Cao, Yingjun Zhang, Zhongqing Wang, Guozhu Liu, Jing Li, Baohua Gu. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges. Pharmacology & Therapeutics 2020; 212 doi: 10.1016/j.pharmthera.2020.107539
402	L.V. Zhuravlyova, O.V. Elhaj. THE ROLE OF RESISTIN IN THE PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE. Inter Collegas 2021; 8(3) doi: 10.35339/ic.8.3.157-162
403	Annalisa Pezzoli, Ludovico Abenavoli, Marialaura Scarcella, Carlo Rasetti, Gianluca Svegliati Baroni, Jan Tack, Emidio Scarpellini. The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels. Medicina 2025; 61(3) doi: 10.3390/medicina61030387
404	Ysabel C. Ilagan-Ying, Bubu A. Banini, Albert Do, Robert Lam, Joseph K. Lim. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice. Current Gastroenterology Reports 2023; 25(10) doi: 10.1007/s11894-023-00883-8
405	Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement. Expert Review of Anticancer Therapy 2022; 22(4) doi: 10.1080/14737140.2022.2052276
406	Tony (Dazhong) Huang, Jason Behary, Amany Zekry. Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Internal Medicine Journal 2020; 50(9) doi: 10.1111/imj.14709
407	J.M. Carrascosa, E. Vilarrasa, I. Belinchón, P. Herranz, J. Crespo, F. Guimerá, A. Olveira. Abordaje común del paciente con psoriasis y riesgo de esteatosis hepática metabólica: recomendaciones de un grupo de expertos multidisciplinar. Actas Dermo-Sifiliográficas 2023; 114(5) doi: 10.1016/j.ad.2023.01.004
408	Yanqin Wang, Jiaqi Bo, Zhonghua Zhao, Yuhang Han, Qianqian Zhang, Lixin Liu. Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis. Life Sciences 2023; 332 doi: 10.1016/j.lfs.2023.122086
409	Sarah Theurer, Julia Kälsch, Suzan Schwertheim, Simone Kathemann, Hideo A. Baba. Histopathologische Diagnostik und Differenzialdiagnostik der nichtalkoholischen Fettlebererkrankung. Der Pathologe 2020; 41(5) doi: 10.1007/s00292-020-00800-0
410	Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis. Gene Expression 2019; 19(3) doi: 10.3727/105221619X15553433838609
411	Vicki Shah, Thomas Colletti, Nancy Reau. Could the answer to NAFLD be hidden in diabetic therapy? The impact of T2DM treatment on NAFLD. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000100
412	Kaoru Shibayama, Chie Furushima, Minako Saka, Takako Sakamoto, Hirokazu Takahashi. Barriers to lifestyle modification in patients with non-alcoholic fatty liver disease: a scoping review. Journal of Rural Medicine 2024; 19(1) doi: 10.2185/jrm.2023-026
413	Yan Li, Chunyi Wang, Yu Jin, Haibo Chen, Meiqun Cao, Weimin Li, Huanmin Luo, Zhengzhi Wu. Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats. Biomedicine & Pharmacotherapy 2020; 126 doi: 10.1016/j.biopha.2019.109734
414	Mousa Khalafi, Sara K Rosenkranz, Faeghe Ghasemi, Shokoufeh Kheradmand, Aref Habibi Maleki, Mallikarjuna Korivi, Jung-Piao Tsao. Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis. Nutrition & Metabolism 2025; 22(1) doi: 10.1186/s12986-024-00885-x
415	José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, Claudia P. Oliveira. Non-pharmacological management options for MAFLD: a practical guide. Therapeutic Advances in Endocrinology and Metabolism 2023; 14 doi: 10.1177/20420188231160394
416	Dana Gharib, Mohammed Mohammed, Taha Al-Karboly, Heero Faraj, Kawa Mahmood, Nasr Qazi, Karok Salih, Omar Azeez. VALUE OF TRANS-ABDOMINAL ULTRASOUND-GUIDED PERCUTANEOUS LIVER BIOPSY IN PATIENTS WITH FOCAL OR DIFFUSE LIVER LESIONS IN KURDISTAN CENTRE FOR GASTROENTEROLOGY AND HEPATOLOGY IN SULAIMANI CITY. JOURNAL OF SULAIMANI MEDICAL COLLEGE 2020; 10(2) doi: 10.17656/jsmc.10258
417	Qing Gu, Li Cen, Jiawei Lai, Zhongchen Zhang, Jiaqi Pan, Feng Zhao, Chaohui Yu, Youming Li, Chunxiao Chen, Weixing Chen, Zhe Shen. A meta‐analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease. European Journal of Clinical Investigation 2021; 51(2) doi: 10.1111/eci.13446
418	Leyli Zahra Bahreini Boroujeni, Mohammad Mehdi Haghighat_Lari, Abolfazl Ghandi, Seyed Mahmood Hashemian, Rana Shafabakhsh, Zarrin Banikazemi, Mohsen Taghizadeh. Effects of black mulberry leaf extract on liver health and metabolic parameters in rats with high-fat diet-induced liver changes. Obesity Medicine 2024; 50 doi: 10.1016/j.obmed.2024.100554
419	Pierpaolo Pellicori, Muthiah Vaduganathan, João Pedro Ferreira, Faiez Zannad, Arun J. Sanyal. Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes & Metabolism 2022; 48(2) doi: 10.1016/j.diabet.2021.101281
420	Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, Michaela Noreik, Elizabeth Morris, Indrani Manoharan, Kate Tudor, Emma Bodenham, Anna Dunnigan, Susan A. Jebb, Paul Aveyard. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 2021; 115 doi: 10.1016/j.metabol.2020.154455
421	Swati Singh, Anit Kumar, Suruchi Gupta, Rohini Agrawal. Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD). Tissue Barriers 2024; 12(3) doi: 10.1080/21688370.2023.2289830
422	Ahmed Mohamed ElGhandour, Nahla Mohamed Teama, Marwa Abdullah Kamal, Ehab Hassan Nashaat, Amani Mohamed Abdel Ghani, Ahmad Abbas Abdo. Diagnostic and prognostic value of plasma lipocalin-2 levels in patients with metabolic dysfunction–associated steatotic liver disease. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00387-8
423	Maria Styliani Kalogirou, Olga Giouleme. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. World Journal of Transplantation 2022; 12(9): 281-287 doi: 10.5500/wjt.v12.i9.281 Abstract(1361) \| Core Tip(1144) \| Full Article(HTML)(4950) \| Full Article (PDF)-3327K(498) \| Full Article (Word)-121K(116) \| Audio-253K(23) \| Peer-Review Report-220K(209) \| Answering Reviewers-74K(193) \| Times Cited (6) \| Total Visits (6359) \| Open
424	Joana D’Arc Matos França de Abreu, Rossana Sousa Azulay, Vandilson Rodrigues, Sterffeson Lamare Lucena de Abreu, Maria da Glória Tavares, Flávia Coelho Mohana Pinheiro, Clariano Pires de Oliveira Neto, Caio Andrade, Alexandre Facundo, Adriana Guimarães Sá, Patrícia Ribeiro Azevedo, Ana Gregória Pereira de Almeida, Debora Camelo de Abreu Costa, Rogério Soares Castro, Marcelo Magalhães, Gilvan Cortês Nascimento, Manuel dos Santos Faria, Adalgisa de Souza Paiva Ferreira. Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease. Biomedicines 2024; 12(11) doi: 10.3390/biomedicines12112542
425	Wanlu Su, Yuxia Wang, Kang Chen, Jie Wang, Anping Wang, Xulei Tang, Li Yan, Zuojie Luo, Guijun Qin, Lulu Chen, Guang Ning, Yiming Mu. Association between nonalcoholic fatty liver and increased low‐level albuminuria in postmenopausal women in China: A cross‐sectional study. Journal of Diabetes 2021; 13(6) doi: 10.1111/1753-0407.13134
426	Elissa Lin, Aaron Justin Yeoh, Violeta Popov. Nutrition, Weight, and Digestive Health. 2022; doi: 10.1007/978-3-030-94953-2_13
427	Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, Nataliia Zavidniuk, Aleksandr Kamyshnyi. The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence. Viruses 2023; 15(5) doi: 10.3390/v15051072
428	Narges Mobasheri, Leila Ghahremani, Mahin Nazari. A Comprehensive Guide to Non-alcoholic Fatty Liver Disease. 2024; doi: 10.5772/intechopen.1008363
429	Yiling Qian, Yu Zhang, Xiaofang Fan, Hongmei Yan, Xuesong Li, Yujuan Fan, Yuping Song, Shuai Ma, Zheng Hu, Xin Gao, Jialin Yang. Nonalcoholic Fatty Liver Disease and Adverse Pregnancy Outcomes in Women With Normal Prepregnant Weight. The Journal of Clinical Endocrinology & Metabolism 2023; 108(2) doi: 10.1210/clinem/dgac567
430	Ja-Young Kwon. Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment. Clinical and Molecular Hepatology 2022; 28(1) doi: 10.3350/cmh.2021.0359
431	Tiago Cavalcanti IWANAGA, Fernando SANTA-CRUZ, Álvaro Antonio Bandeira FERRAZ, Flávio KREIMER. IMPACT OF SLEEVE GASTRECTOMY ON THE NEUTROPHIL-TO-LYMPHOCYTE RATIO AND THE PLATELET-TO-LYMPHOCYTE RATIO AND ITS RELATIONSHIP WITH POSTOPERATIVE WEIGHT LOSS. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2025; 38 doi: 10.1590/0102-67202025000013e1882
432	Nick Finer. Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. Diabetes, Obesity and Metabolism 2022; 24(S2) doi: 10.1111/dom.14569
433	Shih-Chieh Shao, Liang-Tseng Kuo, Rong-Nan Chien, Ming-Jui Hung, Edward Chia-Cheng Lai. SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews. BMJ Open Diabetes Research & Care 2020; 8(2) doi: 10.1136/bmjdrc-2020-001956
434	Kibo Nam, Mehnoosh Torkzaban, Dina Halegoua-DeMarzio, Corinne E Wessner, Andrej Lyshchik. Improving diagnostic accuracy of ultrasound texture features in detecting and quantifying hepatic steatosis using various beamforming sound speeds. Physics in Medicine & Biology 2023; 68(4) doi: 10.1088/1361-6560/acb635
435	Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 2022; 12(2) doi: 10.3390/diagnostics12020407
436	Jae Young Choi, Tae-Woo Jang, Phil Hyun Song, Seong Hoon Choi, Sae-Kwang Ku, Chang-Hyun Song. Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice. Antioxidants 2022; 11(3) doi: 10.3390/antiox11030580
437	Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, Katrin Bose, Peter R. Mertens, Christos Chatzikyrkou. Association of metabolic syndrome and chronic kidney disease. Obesity Reviews 2024; 25(1) doi: 10.1111/obr.13649
438	Sara Armani, Andreas Geier, Thomas Forst, Uta Merle, David H. Alpers, Martin W. Lunnon. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions. British Journal of Clinical Pharmacology 2024; 90(4) doi: 10.1111/bcp.15990
439	Elaheh Zarean, Mehdi Azizmohammad Looha, Payam Amini, Ali Ahmadi, Pierre-Antoine Dugué. Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: findings from the Shahrekord PERSIAN cohort study. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-15251-4
440	Mohammad Bagher Majnooni, Mari Ataee, Gholamreza Bahrami, Fatemeh Heydarpour, Ina Yosifova Aneva, Mohammad Hosein Farzaei, Touraj Ahmadi‐Juoibari. The effects of co‐administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: A randomized clinical trial. Phytotherapy Research 2021; 35(11) doi: 10.1002/ptr.7279
441	Roberta Rinaldi, Sara De Nucci, Fabio Castellana, Martina Di Chito, Vito Giannuzzi, Endrit Shahini, Roberta Zupo, Luisa Lampignano, Giuseppina Piazzolla, Vincenzo Triggiani, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity. Nutrients 2023; 15(4) doi: 10.3390/nu15040825
442	Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population. International Journal of Environmental Research and Public Health 2020; 17(10) doi: 10.3390/ijerph17103518
443	Véronique Cheff, Mayra Trentin-Sonoda, Amélie Blais, Jean-François Thibodeau, Chet E. Holterman, Alex Gutsol, Christopher R. J. Kennedy, Richard L. Hébert, Michael W. Greene. High fat diet is protective against kidney injury in hypertensive-diabetic mice, but leads to liver injury. PLOS ONE 2023; 18(2) doi: 10.1371/journal.pone.0281123
444	Lan Mou. Exploring the link between non-alcoholic fatty liver disease and depression: a systematic review and meta-analysis of bidirectional risk. American Journal of Translational Research 2025; 17(5) doi: 10.62347/XLVA5738
445	David S. Mathiesen, Asger Lund, Tina Vilsbøll, Filip K. Knop, Jonatan I. Bagger. Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat. Frontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.617400
446	Laura Antonucci, Cristiana Porcu, Eleonora Timperi, Silvano Junior Santini, Gino Iannucci, Clara Balsano, Enrique Ortega. Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity. Journal of Immunology Research 2020; 2020(1) doi: 10.1155/2020/4570219